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 ABSTRACT 
Background and Objectives: 
Solitary nodule of thyroid has increased in incidence in the present day as 
compared to two decades before. Because of possibility of malignancy, some 
clinicians especially those in surgical subspecialties recommended that all 
nodules have to be removed. This study aimed to determine the propotion of 
solitary nodule of thyroid in general population and in relation to age and sex, the 
propotion of solitary nodule of thyroid turning out to be multi-nodular goiter, the 
propotion of euthyroid, hyperthyroid or hypothyroid states in patients presenting 
with solitary nodule of thyroid, to study the role of FNAC in the management of 
solitary nodule of thyroid and to determine the incidence of neoplastic and non-
neoplastic conditions as a cause of solitary  nodule  of thyroid in Govt. 
Royapettah Hospital, Chennai. 
Methods: 
This prospective study includes 50 patients, presenting in Govt. Royapettah 
Hospital, Chennai  who were clinically diagnosed as solitary nodule of thyroid 
between November 2014 to September 2015. All patients were admitted and were 
subjected to thyroid profile, USG and FNAC. All patients were operated   
appropriately depending on the FNAC report. 
Histopathological examination of the operated specimen was done for all 
the patients. Depending on the histo-pathological report appropriate postoperative 
therapies were administered to all the patients and all the patients were followed 
 up appropriately. 
Results: 
Commonest presentation of solitary thyroid nodule was asymptomatic. The 
peak incidence of solitary nodule was observed  in  3rd  to 5th  decade,  constituting 
60% of the cases studied. Females predominated in number over males in 
occurrence of solitary nodule in ratio of 1:5.25.  33%  of  all  clinically  solitary  
nodule  turned out to be multi-nodular goiter. The common causes of solitary 
nodule was MNG (26%),follicular adenoma (24%),adenomatous goiter(24%). 
95% 0f cases presented with euthyroid state. Incidence of malignancy in solitary 
thyroid  nodule was 18%. Male to female  ratio  in  case  of  malignant  nodule  
was1:5.  Incidence of carcinoma in males presenting  as  solitary  nodule  was  
higher  (16.67%) compared  to  that  of  females  (10.20%).  The   most  common  
cause  of malignancy was  papillary  carcinoma  (55%)  followed  by  follicular  
carcinoma (45%). 
Interpretation  and Conclusion: 
Solitary nodule of thyroid is more common in 3rd to 5th decades. Solitary 
nodule of thyroid are more common in  females.  Most  of  the  patients presenting 
with solitary nodule of thyroid are  euthyroid  and  only  a  small percentage  of 
patient with toxicity or hypothyroidism . USG can be accurately used to detect 
patients with multinodulary goiter who clinically present as  solitary nodule of 
thyroid. Common causes of solitary  nodule  of  thyroid  are  MNG,  follicular 
adenoma and adenomatous goiter. Incidence of malignancy in male patients 
 presenting with  solitary  nodule  of  thyroid  is  more  when  compared  to  
female. The most  common  cause of malignancy in  solitary nodule is  papillary     
carcinoma followed by follicular carcinoma. 
Key words: 
Solitary nodule,  malignancy, euthyroid. 
  
 TABLE OF CONTENTS 
 
Sl. No. 
TITLE Page No. 
1 INTRODUCTION 1 
2 AIMS AND OBJECTIVES 3 
3 REVIEW OF LITERATURE 4 – 72 
4 METHODOLOGY 73 – 74 
5 RESULTS 75 – 87 
6 DISCUSSION 90 – 95 
7 CONCLUSION 96 – 97 
8 SUMMARY 98 – 99  
9 BIBLIOGRAPHY 100 – 106  
10 ANNEXURES 107 - 116 
11 CONSENT FORM 117 
12 MASTER CHART 118 – 120 
13 KEY TO MASTER CHART 121 
 
  
 LIST OF FIGURES 
Sl.No. Title Page No. 
1 Dr. Theodore Kocher 5 
2 Dr. Kocher Bilroth 9 
3 Arterial supply of Thyroid 11 
4 Venous Drainage of Thyroid 14 
5 Lymphatic Drainage of Thyroid Gland 16 
6 Lymphatic Basins High Risk for Metastasis 19 
7 Crossectional View of Thyroid Region 22 
8 Zuckercandl’s Tubercle 25 
9 Superior Laryngeal Nerve  Course Variations 26 
10 Histology of Thyroid Gland 30 
11 Physiology of Thyroid Gland 33 
12 Molecular Pathway of Thyroid Hormone 38 
13 
TNM Staging of well differentiated Thyroid 
Carcinoma 
56 
14 Thyroidectomy Incision  65 
15 Thyroidectomy Steps 67 
16 
Prognostic index for well differentiated Thyroid 
Carcinoma 
72 
17 Clinical Pictures 88 
 
 
 CERTIFICATE BY THE  GUIDE 
 
 
This is to certify that the dissertation titled “A CLINICAL STUDY OF 
SOLITARY NODULE OF THYROID”  is a bonafide research work done by 
Dr.Kenny Robert.J , Post Graduate    in M.S. General Surgery, Kilpauk Medical 
College, Chennai under my direct guidance and supervision in my satisfaction, in 
partial fulfillment of the requirements for the degree of    M.S. General Surgery 
 
 
 
 
 
 
 
 Date   :   Dr.V. Ramalakshmi M.S., 
                            Professor, 
 Place   :                                           Department of General Surgery,  
                                                                  Kilpauk Medical College 
                                                                     Chennai - 10    
                                                                                                                
 ENDORSEMENT BY THE HOD AND 
HEAD OF THE INSTITUTION 
 
This is to certify that the dissertation titled “A  
CLINICAL STUDY OF SOLITARY NODULE OF THE THYROID”  
is a  bonafide research work done by DR.KENNY ROBERT J, Post 
Graduate  in M.S. General Surgery, Kilpauk Medical College, Chennai 
under the guidance of Dr.V.Ramalakshmi M.S., Professor, Department of 
General Surgery, Kilpauk Medical College, Chennai. 
 
 
 
 
 
Dr.P.N.Shanmugasundaram M.S., Dr.R.Narayana Babu  M.D.DCH 
Professor  and  Head,    Dean, 
Department  of General Surgery, Kilpauk Medical College, 
Kilpauk  Medical  College,  Chennai-10 
Chennai-10 
 
 
 
Date: Date: 
 
 
Place: Place: 
  
  
 PL
A
G
IA
R
IS
M
 
      
 ACKNOWLEDGEMENT 
 
My sincere thanks to Prof. Dr R. Narayana Babu, M.D, DCH, Dean, 
Kilpauk Medical College and Hospital for allowing me to conduct this study in 
the Department of General Surgery, Government Royapettah Hospital, Chennai. 
I am extremely grateful to Dr.P.N.Shanmugasundaram, M.S, Professor 
and Head of the Department of General Surgery, Government Kilpauk Medical 
college for his encouragement and permission in granting unrestricted access to 
utilising the resources of the Department. 
I thank my mentor and guide Dr.V.Ramalakshmi, M.S, Professor of 
General Surgery, Government Royapettah Hospital for her valuable guidance 
during the tenure of my course. 
I  thank   my   Professors    Dr.   R.Kannan   and   Dr S. Balakrishnan  for 
their support and guidance. 
I   also   acknowledge   my   assistant    professors                                                
Dr.  S. Thirunavukkarasu, Dr. Suresh Babu, and Dr. Rajkumar, for their valuable 
support and timely help rendered to complete this study. 
I thank my colleagues Dr.Varun, Dr. Sarayu, Dr. Vimala.G, Dr. Deepan, 
Dr. Radha  Dr. Kathirvel, Dr. Lingesh who helped me throughout my study. 
I would like to thank the entire medical and paramedical staff of the 
Department of General Surgery. 
  My utmost thanks to all my patients who cooperated to complete my 
dissertation. Without their help it would have been impossible for me to 
complete this study. 
I thank my family for their great help and support. 
Last but not the least, I thank God for being the prime force in guiding me 
throughout. 
 
  
 LIST OF ABBREVATIONS 
 
AG   Adenomatous goiter   
ATC   Anaplastic thyroid carcinoma 
ECG   Electrocardiogram 
FNAC   Fine needle aspiration Cytology 
HPE   Histopathological examination 
MIT   Monoiodotyrosine 
MTC   Medullary thyroid Carcinoma 
RLN   Recurrent laryngeal nerve 
SNT   Solitary nodule thyroid 
T3   Tri-iodotyrosine 
T4   Thyroxine 
TBG   Thyroxine binding globulin 
TR   Thyroxine hormone receptor 
USG   Ultrasonography 
Tg   Thyroglobulin 
  
 TABLE OF CONTENTS 
 
Sl. No. 
TITLE Page No. 
1 INTRODUCTION 1 
2 AIMS AND OBJECTIVES 3 
3 REVIEW OF LITERATURE 4 – 72 
4 METHODOLOGY 73 – 74 
5 RESULTS 75 – 87 
6 DISCUSSION 90 – 95 
7 CONCLUSION 96 – 97 
8 SUMMARY 98 – 99  
9 BIBLIOGRAPHY 100 – 106  
10 ANNEXURES 107 - 116 
11 CONSENT FORM 117 
12 MASTER CHART 118 – 120 
13 KEY TO MASTER CHART 121 
 
  
 LIST OF FIGURES 
Sl.No. Title Page No. 
1 Dr. Theodore Kocher 5 
2 Dr. Kocher Bilroth 9 
3 Arterial supply of Thyroid 11 
4 Venous Drainage of Thyroid 14 
5 Lymphatic Drainage of Thyroid Gland 16 
6 Lymphatic Basins High Risk for Metastasis 19 
7 Crossectional View of Thyroid Region 22 
8 Zuckercandl’s Tubercle 25 
9 Superior Laryngeal Nerve  Course Variations 26 
10 Histology of Thyroid Gland 30 
11 Physiology of Thyroid Gland 33 
12 Molecular Pathway of Thyroid Hormone 38 
13 
TNM Staging of well differentiated Thyroid 
Carcinoma 
56 
14 Thyroidectomy Incision  65 
15 Thyroidectomy Steps 67 
16 
Prognostic index for well differentiated Thyroid 
Carcinoma 
72 
17 Clinical Pictures 88 
 
 
1 
 
INTRODUCTION 
The solitary thyroid nodule has aroused interest of surgeons, since the 
time of Warren H Cole (1949) and his study concluded that incidence of 
malignancy is greater when compared with multinodular goitre. 
1 
Thyroid nodules are commonly encountered, though varying in incidence 
in different geographical regions
2
. The prevalence of palpable nodules in general 
population is 4-7%. Solitary nodules of thyroid occur frequently in women in 
the ratio 4:1 compared to men. The proportion of malignancy in Solitary nodules 
is 10 to 30 %. 
DEFINITION: 
A single nodule in the thyroid is a clinical entity of pathological 
significance. A solitary nodule is defined as “a palpable single clinically 
detected nodule in the thyroid gland that is in general otherwise normal”. It is 
necessary to consider the status of opposite lobe when considering the 
‘solitariness’ of the nodule. Ignoring palpability of opposite lobe would likely to 
lead to a higher incidence of solitary nodule turning out to be multi-nodular 
goiter. 
The usual presentation of a thyroid nodule is an asymptomatic mass, 
which is discovered by either the patient or the clinician. Nodules of at least 
0.5cm to 1cm can be usually be detected by palpation. It can be difficult to 
palpate any nodule in patient with a thick skin and short neck. Further clinically 
2 
 
impalpable nodules, which are indolent are usually picked up during imaging 
studies done for other causes. 
The importance of discrete swelling lies in the risk of neoplasia compared 
with other thyroid swellings. Hence proper clinical examination, investigations 
and FNAC helps in the early identification and appropriate management of 
solitary nodule thyroid. Favourable prognosis with reduced mortality and 
morbidity occurs for cases picked up at a earlier stage and for benign lesions. 
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AIMS AND OBJECTIVES 
1. To determine the incidence of solitary nodule thyroid in relation to age and 
sex. 
2. To determine the proportion  of solitary nodule of thyroid turning out to be 
multi nodular goiter. 
3. To study the percentage of euthyroid, hyperthyroid or hypothyroid states in 
patients presenting with solitary nodule of thyroid. 
4. To study the role of FNAC in the management of solitary nodule of thyroid. 
5. To determine the incidence of adenoma, carcinoma and thyroiditis as a  
cause of solitary nodule of thyroid in Govt. Royapettah Hospital , Chennai.  
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REVIEW OF LITERATURE 
Historical Review: 
The term “Goiter” is derived from the Latin guttur known as throat.  The 
enlargement of the thyroid was reported in 2700 BC. In 1619, Hieronymus 
Fabricius ab Aquapendente stated that goiters arose from the thyroid gland. 
Thomas Wharton coined the term thyroid (Greek thyreoeides, shield-shaped). In 
1776 Albrecht von Haller classified the thyroid  as a ductless gland and mentioned 
its functions. 
The first documented thyroid surgery for goiters was by Roger Frugardi in 
1170. He inserted two setons were inserted at right angles into the goiter, 
tightening them twice daily until the goiter separated. Caustic powder was used to 
treat the open wound. Due to the high morbidity and mortality thyroid surgeries 
were not done until the 19th century, Advances in asepsis, anaesthesia and better 
understanding of anatomy of thyroid gland increased the number of safe surgeries 
subsequently. The most notable thyroid surgeons were Emil Theodor Kocher 
(1841– 1917) and C.A. Theodor Billroth (1829–1894), who performed several 
surgeries with increasingly successful results. After total thyroidectomy, patients 
developed myxedema with cretinous features.  
Subsequently it was treated by George Murray using a subcutaneous 
injection of an extract of sheep's thyroid. Edward Fox showed that oral thyroxine 
also allieviated the symptoms.   
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In 1909, Kocher was awarded the Nobel Prize for medicine in recognition 
“for his works on the physiology, pathology, and surgery of the thyroid 
gland.”
9 
 
 
 
 
 
 
 
 
Dr. Theodore Kocher – Father of Thyroid Surgery 
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The Anatomic and Surgical history of the thyroid  gland is shown in Table 1
10
. 
Table 1.  Anatomic and Surgical History of the  Thyroid Gland 
 
Egypt 2780-2280 
   B.C. 
Statues show signs of Graves' disease 
India 2000-
1000B.C. 
The Hindu Rig Veda mentions tracheal 
cannulation 
China 1600B.C. Used burnt sponge and seaweed to treat goiters 
India 400B.C. The Ayur Veda discusses the treatment and 
diagnosis of goiters 
Egypt 69-30 B.C. A temple wall engraving shows Cleopatra with 
goiter 
Celsus 50-30 B.C. Described the appearance and surgery of cystic 
goiters 
Galen ( 130-200 
  A.D.) 
Considered the thyroid a buffer between the heart 
and the brain. Called the thyroid cartilage thyreos, 
  meaning "oblong shield." 
da Vinci (1452-
1519) 
 Provided illustrations of the thyroid glands 
Vesalius 1543 Wrote of and illustrated the "Glandes laryngis 
radici adnatae" (thyroid glands) in Fabrica 
Fabricius 1620 Thought of a goiter as an enlargement of the 
thyroid glands 
Coindet 1820 Recommended iodine as a treatment for goiter 
Graves 1835 Observed and described effects of an overactive 
thyroid 
Owen 1852 Described the parathyroid gland of a rhinoceros 
Gull 1873 Described primary myxedema 
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Sandström 1880 Described the parathyroid glands, suggesting they 
were embryonic portions of the thyroid 
Rehn 1880 Performed a thyroidectomy to treat exophthalmic 
goiter 
Steida 1881 Described thyroid development 
Billroth 1881 Reported 48 thyroidectomies performed since 
1877, in which only four patients died. First to use 
artery forceps to prevent and stop hemorrhage. 
Noted the presence of post-surgical tetany in many 
C.MayoErdheim Hals  1906 Studied the relationship between parathyroid 
glands and calcium metabolism 
Crile&C. Mayo 1906 Reported on 132 cases in which he performed a 
Radical neck excision.  
C.MayoErdheim Hals  1907 First to use the term "hyperthyroidism" 
Mac Callum and 
Voegtlin 
1908 Studied hypoparathyroidism and its relation to low 
serum calcium. 
C. Jackson &C. 
Mayo 
1909 
 
1912 
 
 
Performed the first modern tracheostomy 
 
Division of Strap muscles for large Goitre 
 
 
C. Jackson,C. 
Mayo& Kendall -
Schlagenhaufer 
1914 Isolated  thyroxine 
Hanson 1924 Extracted parathyroid hormone 
Harington 1926 Determined the chemical structure of thyroxine 
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EMBRYOLOGY
10
 
 
Normal Development 
By the end of the third week, the thyroid gland appears as an epithelial 
proliferation. It arises as a midline bilobed diverticulum in front of pharyngeal 
gut.  The gland ascends cranial along with   the tongue with elongation of the 
embryo. The thyroid gland and foramen caecum are connected by thyroglossal 
duct 
The thyroglossal duct loses its lumen at 5 weeks. The pyramidal lobe of 
thyroid is commonly seen. Its due to persistence of caudal end of the thyroglossal 
duct. The gland is seen developing as two lateral wings with an intervening 
isthmus. Follicles are seen in second month of intra-uterine life .Colloid occurs in 
the eleventh week. The neural crest cells of embryo migrate into ultimobranchial 
body. Ultimo-branchial body gets dispersed into thyroid gland to form the 
parafollicular C cells of thyroid. 
Lingual Thyroid 
Aberrant thyroid tissue are found anywhere along the path of descent. 
Most commonly present at the base of tongue and it’s called lingual thyroid.  
Median analage fails to descent leading to formation of lingual thyroid.  The 
lingual thyroid gland sometimes is the only thyroid tissue present. Radioactive 
iodine uptake study is essential for diagnosis. 
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Thyroglossal duct usually gets obliterated. The following are its remnants 
1) Pyramidal lobe & 2) thyroglossal cyst Thyroglossal cyst should not be 
aspirated. After evaluation for presence of normal thyroid tissue, all fragements 
of duct, cyst and mid portion of hyoid is removed (Sistrunk procedure). Improper 
removal leads to recurrence 
Accessory Ectopic Thyroid Tissue: 
 These are thyroid tissue outside the pathway of normal descent. The 
common sites are Mediastinal, Ovarian, Intracheal, Intratracheal, Lateral to 
jugular, Sella Turcica, Intra-oesophageal etc. 
 
 
 
 
 
 
 
 
 
Kocher Billroth 
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ANATOMY 
General Topography: 
The thyroid gland consists typically of two lobes, a connecting isthmus, 
and an ascending pyramidal lobe. In 7 % right lobe is found to be smaller than the 
left. Complete absence of right lobe is seen in 1.7%. Commonly, in about 50  
percent the pyramidal lobe is absent and the isthmus  in about 10 percent. A 
minute epithelial tube or fibrous cord, the thyroglossal duct remnant almost 
always extends between  the thyroid gland and the foramen cecum of the tongue. 
The thyroid gland normally extends from the level of the 5th cervical 
vertebra to the body of the 1st thoracic vertebra. The normal thyroid gland weighs 
about 10g  to 30 g in the adult. Each lobe is approximately 5 cm in length, 3 cm at 
its greatest width, and 2-3 cm thick.
34 The isthmus connecting the two lobes is 
about 1.3 cm in breadth. The lobes have a broad lower portion and a relatively 
conical apex. Capsule of the Thyroid Gland .The thyroid gland is covered by 
connective tissue capsule (True capsule) which is continuous with the septa, and 
which makes up the stroma of the organ.  
External to the true capsule is a false capsule derived from pretracheal 
fascia false capsule. It is also called the perithyroid sheath or surgical capsule. 
Anteriorly and laterally this fascia is well developed; posteriorly it is thin and 
loose, permitting enlargement of the thyroid gland posteriorly. 
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         There is a thickening of the fascia that fixes the back of each lobe to the 
cricoid cartilage called the ligaments of Berry. 
The superior parathyroid glands normally lie between the true capsule of 
the thyroid and the fascial false capsule. The inferior parathyroids may be between 
the true and false capsules, within the thyroid parenchyma, or lying on the outer 
surface of the fascia 
Vascular Supply 
The thyroid gland has a great blood supply per gram of tissue.
35 One 
consequence is that hemostasis is a major problem of thyroid surgery, especially in 
patients with toxic goiter. 
Arteries 
Two paired arteries, the superior and inferior thyroid arteries, and an 
inconstant midline vessel, the thyroid ima artery, supply the thyroid gland 
 
 
 
 
 
Fig. 3: Arterial Supply of Thyroid Gland 
12 
 
The thyroid ima artery is only occasionally present.” (Modified from Tzinas 
S, Droulias C, Harlaftis N, Akin JT Jr, Gray SW, Skandalakis JE. Vascular 
patterns of the thyroid gland. Am Surg 1976; 42:639-644;) 
Superior Thyroid Artery 
The superior thyroid artery arises from the external carotid artery just 
above, at, or just below the bifurcation of the common carotid artery. It passes 
downward and anteriorly to reach the superior pole of the thyroid gland. In part of 
its course, the artery parallels the external branch of the superior laryngeal nerve 
which supplies the cricothyroid  muscle and the cricopharyngeus muscle. 
 There are six branches of the superior thyroid artery (Fig. 1-56) namely the 
infrahyoid, sternocleidomastoid, superior laryngeal, cricothyroid, inferior 
pharyngeal constrictor, and terminal branches of the artery for the blood supply of 
the thyroid and parathyroid glands. Usually there are two branches to the thyroid 
the anterior and posterior, but occasionally there may be a third, the so-called 
lateral branch. 
Branches of the superior thyroid artery: 
At the superior pole, the superior thyroid artery divides into anterior and 
posterior branches. The anterior branch anastomoses with the contralateral 
artery;
36 the posterior branch anastomoses with branches of the inferior thyroid 
artery. From the posterior branch, a small parathyroid artery passes to the superior 
parathyroid gland. 
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Weiglein
38 reported a rare variation of blood supply to the thyroid gland. 
In this case, the right inferior thyroid artery, was replaced by an artery originating 
from the right internal thoracic artery. The left inferior thyroid artery was 
replaced by an artery arising from the vertebral artery. 
Inferior Thyroid Artery: 
The inferior thyroid artery usually arises from the thyrocervical trunk, but in 
about 15 percent of individuals it arises directly from the subclavian artery.
39 
The inferior thyroid artery ascends behind the carotid artery and the 
internal jugular vein, passing medially and posteriorly on the anterior surface of 
the longus coli muscle. After piercing the prevertebral fascia, the artery divides 
into two or more branches as it crosses the ascending recurrent laryngeal nerve. 
The recurrent laryngeal nerve may pass anterior or posterior to the artery, 
or between its branches. The lowest branch sends a twig to the inferior 
parathyroid gland and supplies the lower pole of the thyroid gland. The upper 
branch supplies the posterior surface of the gland, usually anastomosing with a 
descending branch of the superior thyroid artery. On the right, the inferior thyroid 
artery is absent in about 2 percent of individuals. On the left, it is absent in about 
5 percent (Hunt et al.).
40
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Thyroidea Ima Artery: 
The thyroid ima artery is unpaired and inconstant. It arises from the 
brachiocephalic artery, the right common carotid artery, or the aortic arch. It 
occurs in about 10 percent of individuals, according to Montgomery.
42
 It’s 
position anterior to the trachea makes it important in tracheostomy. 
Veins: 
Veins of the thyroid gland form a plexus of vessels lying in the substance 
and on the surface of the gland. The plexus is drained by three pairs of veins, the 
superior, middle, and inferior thyroid veins. 
The Venous Drainage of the thyroid gland. 
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Superior Thyroid Vein: 
It accompanies the superior thyroid artery. As it emerges from the 
superior pole of the thyroid, the vein passes superiorly and laterally across the 
omohyoid muscle and the common carotid artery to enter the internal jugular 
vein alone or with the common facial vein. 
Middle Thyroid Vein: 
The middle thyroid vein arises on the lateral surface of the gland at about 
two-thirds of its antero posterior extent. It crosses the common carotid artery  to 
open into the internal jugular vein. The importance of these middle thyroid veins 
is in their vulnerability during thyroidectomy. 
Inferior Thyroid Vein: 
The inferior thyroid vein is the largest and most variable of the thyroid 
veins; the right and left sides are usually asymmetric. The right vein leaves the 
lower border of the thyroid gland, passes anterior to the brachiocephalic artery, 
and enters the right brachiocephalic vein. The left vein crosses the trachea to 
enter the left brachiocephalic vein. Rarely, the right vein crosses the trachea to 
enter the left brachiocephalic vein, sometimes forming a common trunk with the 
left vein. This common trunk is called the thyroid ima vein. 
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Lymphatics: 
Several broad patterns of lymphatic drainage of the thyroid gland have been 
proposed. Each conceptualization is based on the same facts; each is correct. We 
will follow that of Hollinshead
43
. The actual drainage is as shown in. 
Three concepts of the lymphatic drainage of the thyroid gland 
 
 
 
 
Lymphatic Drainage of the Thyroid Gland 
 
 
 
 
 
 
 
 
Patterns of Lymphatic Drainage: 
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Median Superior Drainage  
Three to six vessels arise from the superior margin of the isthmus and from 
the medial margins of the lateral lobes. These vessels pass in front of the larynx to 
end in the digastric lymph nodes. Some vessels may enter one or more 
prelaryngeal ("Delphian") nodes just above the isthmus. Secondary drainage may 
be to upper jugular nodes on either side or to pretracheal nodes below the thyroid 
by a vessel passing from the Delphian nodes downward over the front of the 
thyroid. 
 It has been suggested that there is a connection between the lymphatic 
drainage of the superior thyroid artery and the orbit by way of the jugular chain of 
cervical lymph nodes.
44 In neither the orbit nor the eye itself can lymphatic vessels 
be demonstrated.
45 The immediate cause of exophthalmus associated with thyroid 
disease is the enlargement of the extraocular muscles, especially the inferior rectus 
and inferior oblique. Thyroid antigen or antigen-antibody complexes reaching the 
eye from the thyroid gland produce an autoimmune response in the extraocular 
muscles. 
Median Inferior Drainage 
Several lymph vessels drain the lower part of the isthmus and the lower 
medial portions of the lateral lobes. They follow the inferior thyroid veins to end in 
the pretracheal and brachiocephalic nodes. 
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Right and Left Lateral Drainage 
Lymphatic trunks arise from the lateral border of each lobe. Superiorly they 
pass upward with the superior thyroid artery and vein. Inferiorly they follow the 
inferior thyroid artery. Between these two groups, some vessels pass laterally, 
anteriorly, or posteriorly to the carotid sheath to reach the lymph nodes of the 
internal jugular chain 
Posterior Drainage 
Posterior lymphatic vessels arise from the inferomedial surfaces of the 
lateral lobes to drain into nodes along the recurrent laryngeal nerve. Occasionally, a 
posterior ascending trunk from the upper part of the lobe reaches the 
retropharyngeal nodes. 
Metastatic Spread 
A representation of lymph node regions of importance for management of 
thyroid carcinoma is seen in. Lymph node groups at the highest risk for regional 
metastasis from differentiated thyroid carcinoma are shown in. 
  
19 
 
“Lymph node regions of importance for management of  thyroid 
carcinoma” 
 
 
 
 
 
 
 
 
Diagram illustrating lymph node groups at highest risk for regional 
metastasis 
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Innervation 
The thyroid gland is innervated by the sympathetic system from the 
superior, middle, and inferior ganglia of the cervical chain. But in thyroid surgery 
the recurrent and superior laryngeal nerves of the parasympathetic (vagus) system 
(which play no role in the innervation of the gland) are of utmost importance, so 
we consider them here. 
Recurrent Laryngeal Nerve 
Normal Anatomy 
The right and left recurrent laryngeal nerves are intimately related to the 
thyroid gland. The right recurrent nerve branches from the vagus as it crosses 
anterior to the right subclavian artery. The right recurrent nerve loops around the 
subclavian artery from posterior to anterior, crosses behind the right common 
carotid and ascends in or near the tracheoesophageal groove. It passes posterior to 
the right lobe of the thyroid gland to enter the larynx behind the cricothyroid 
articulation and the inferior cornu of the thyroid cartilage. 
The left recurrent nerve arises, just distal to the origin of the left subclavian 
artery from the aortic arch. It loops under the ligamentum arteriosum and the aorta, 
and ascends in the same manner as the right nerve. Both nerves cross the inferior 
thyroid arteries near the lower border of the middle third of the gland. 
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Variations 
Several variations may occur in the courses of the recurrent nerves. All 
serve to increase the possibility of injury to the nerve during thyroid surgery. Katz 
and Nemiroff 
47
visualized 1,117 recurrent laryngeal nerves. They reported that 747 
(63%) had trifurcation or bifurcation of the nerve away (0.5cm) from cricoid 
cartilage. 
In about 1 percent of patients, the right recurrent nerve arises normally from 
the vagus, but passes medially almost directly from its origin to the larynx without 
looping under the subclavian artery. In these cases, the right subclavian artery 
arises from the descending aorta and passes to the right behind the esophagus. This 
anomaly is asymptomatic, and the thyroid surgeon will rarely be aware of it prior 
to operation. Even less common is a nonrecurrent left nerve in the presence of a 
right aortic arch and a retroesophageal left subclavian artery. 
In the lower third of its course, the recurrent laryngeal nerve ascends behind 
the pretracheal fascia at a slight angle to the tracheoesophageal groove. In the 
middle third of its course, the nerve may lie in the groove, medial to the 
suspensory ligament of the thyroid gland (ligament of Berry), within the ligament, 
or within the substance of the thyroid gland. 
A study by Skandalakis et al.
49   revealed that most common nerve lay is in 
the tracheoesophageal groove next common lie is para-tracheal, other common 
types are  Para-esophageal and rarely intra-glandular nerves.   
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The course of the recurrent laryngeal nerve at the thyroid gland. About half 
the nerves were found in the groove between the trachea and the esophagus. A, 
Lateral view. B, Cross-sectional view 
 
 
 
 
 
 
 
 
 
 
 
.  
 
In the case of a unilateral single trunk, the nerve passes just behind the 
cricothyroid joint and can be easily identified. Variations were mainly 
limited to the level of the extralaryngeal division of the inferior laryngeal 
nerve. Thus, the surgeon can rely on precise and consistent landmarks in 
this part of the body, as in other anatomical locations. 
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The recurrent laryngeal nerve is safest and least visible when it lies in the 
tracheoesophageal groove. It is most vulnerable when it traverses the thyroid 
parenchyma. Where it runs in the suspensory ligament of the thyroid, it must be 
identified and protected before the ligament is divided. 
The recurrent laryngeal nerve crosses the inferior thyroid artery at the 
middle third of the gland. It may lie anterior or posterior to, or between the 
branches of the artery.
52 Lekacos et al.
53 reported that most recurrent laryngeal 
nerves (approximately 80%) are located either posterior to or between the branches 
of the inferior thyroid artery. The three major types of crossings were shown 
previously in Fig. 1-57A-C. A series by Skandalakis et al.
54 showed that the right 
nerve most frequently lay between arterial branches (48 percent); the left nerve 
was usually behind the artery (64 percent). Table 1-6 shows the relative incidence 
of the types of crossing. No one pattern can be considered "normal"; the surgeon 
must be prepared for any configuration of artery and  nerve Kreyer and 
Pomaroli
56
reported an anastomosis between the external branch of the superior 
laryngeal nerve and the recurrent laryngeal nerve. Sturniolo et al.
57 emphasized 
that the secret to avoiding injury to the recurrent laryngeal nerve during thyroid 
surgery is as follows: (1) deep knowledge of the surgical anatomy of the thyroid 
region; (2) total extracapsular thyroidectomy; (3) a thorough search, identification, 
and exposure of the nerve itself; and (4) following the course of the nerve with 
care. 
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Marchesi et al.
59
reported an occurrence rate of 0.34% for a nonrecurrent 
inferior laryngeal nerve on the right side, and extreme rarity on the left side. They 
report seven cases of nonrecurrent laryngeal nerve, and emphasize the diagnostic 
accuracy of angio- MR for the anatomic identification of the vascular anomaly that 
invariably occurs with the nerve malformation. 
 The nonrecurrent nerve (left or right, when present) may pass directly to the 
larynx with no relation to the inferior thyroid artery, or such a nerve may loop 
around the artery. 
 Miyauchi et al.
62 reported good results with simple neurorrhaphy or with 
graft (vagus nerve - ansa cervicalis) of the injured recurrent nerve. Their 8 patients 
recovered from hoarseness, and maximum phonation improved.  
Exposure 
 Exposure of the recurrent nerve during any procedure on the thyroid is a 
sound surgical principle and should be done wherever possible. If the nerve cannot 
be found readily, the surgeon must avoid the areas in which it may be hidden. 
Fibrosis, increased bleeding, and lack of clear anatomic relationships are 
responsible for most nerve injuries. Postoperative exploration for hemorrhage also 
is associated with a higher risk of nerve injury.
64 
At one time the recurrent nerve was considered so delicate that "if a 
recurrent laryngeal nerve is seen during thyroidectomy, it is injured.
66 It is now 
believed that visual identification, with avoidance of traction, compression, or 
25 
 
stripping the connective tissue is most ideal. Complete anatomic dissection is not 
required, but simple exposure will not destroy it., Jatzko et al.
67 noted a 
significantly higher rate of injury to the recurrent laryngeal nerve when it was not 
identified (5.2%) than when it was exposed (1.2%). 
The recurrent laryngeal nerve forms the medial border of a triangle 
bounded superiorly by the inferior thyroid artery and laterally by the common 
carotid artery. The nerve can be identified where it enters the larynx just posterior 
to the inferior cornu of the thyroid cartilage.
68 If the nerve is not found, a 
nonrecurrent nerve should be suspected, especially on the right. 
Pelizzo et al.
69 
advised identification of Zuckerkandl tuberculum (lateral 
portion of thyroid lobe) to delineate the nerve. 
 
 
 
 
 
Zuckerkandl's tuberculum size. 0, unrecognizable; 1, only a thickening of the 
lateral edges of the thyroid lobe; 2, smaller than 1 cm; 3, larger than 1 cm. 
 
The tubercle of Zuckerkandl is the  posterior most extension of the lateral 
lobes of thyroid gland. It is present at the level of the ligament of Berry
70,71. In the 
lower portion of the course of the recurrent laryngeal nerve, the nerve can be 
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palpated as a tight strand over the tracheal surface. There is more connective tissue 
between the nerve and the trachea on the right than on the left. 
Superior Laryngeal Nerve 
 The superior laryngeal nerve arises from the vagus nerve just inferior to its 
lower sensory ganglion just outside the jugular foramen of the skull. The nerve 
passes inferiorly, medial to the carotid artery. At the level of the superior cornu of 
the hyoid bone it divides into a large, sensory, internal laryngeal branch and a 
smaller, motor, external laryngeal branch, serving the cricothyroid muscle
72 and 
the cricopharyngeus. The point of division is usually within the bifurcation of the 
common carotid artery. 
Sun and Dong
73
dissected 60 adult cadavers (120 superior laryngeal nerves) 
and reported the morphology and topography of the superior laryngeal nerve, its 
branches, its anastomoses with the cervical sympathetic, and its relations to the 
thyroid gland. An anastomotic loop connecting the cervical sympathetic chain and 
the distal laryngeal nerve was present in 111 of the 120 cases. The morphology of 
this loop made it possible to define five different types. 
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Variations of laryngeal nerves. Type I, V-shaped in 94 sides (78.3 ± 3.8%). 
Type II, U- shaped in 8 sides (6.7 ± 2.3%). Type III, Mixed in 14 sides (11.7 ± 
2.9%). Type IV, Juxtaposed-double in 1 side (0.8 ± 0.8%). Type V, Juxtaposed-
triple in 1 side (0.8 ± 0.8%). SLN, superior laryngeal nerve; ILN, internal 
laryngeal nerve; SCG, superior cervical ganglion; CT, communicating twig; ELN, 
external branch of laryngeal nerve; CTB, cricothyroid muscle branch; GB, thyroid 
branch. 
To prevent iatrogenic injury of the superior laryngeal nerve during surgical 
dissection near the thyroid apex in the neck, el-Guindy and Abdel-Aziz
74 
recommended anatomical localization of the nerve in the viscerovertebral angle, 
functional identification, and post- operative analysis. 
Internal Laryngeal Nerve 
 The internal laryngeal branch pierces the thyro-hyoid membrane with the 
superior laryngeal branch of the superior thyroid artery to enter and supply the 
larynx. The internal branch is rarely identified by the surgeon; identification occurs 
only in those cases where a greatly enlarged upper pole of the thyroid gland rises 
above the superior border of the thyroid cartilage (Fig. 1-70). The internal 
laryngeal nerve provides general sensory fibers to the larynx and the area of the 
pyriform recess of the laryngopharynx. It also provides parasympathetic fibers for 
the glandular elements and some taste fibers that supply taste buds around the 
epiglottis. 
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External Laryngeal Nerve: 
The external laryngeal branch, together with the superior thyroid vein and 
artery, passes under the sternothyroid muscles, posterior and medial to the vessels. 
The nerve then passes beneath the lower border of the thyrohyoid muscle to 
continue inferiorly to innervate the cricothyroid muscle. In addition to its 
contribution to phonation, the cricothyroid muscle plays a major role in the overall 
regulation of breathing by its control of expiratory resistance and flow.
75
 
Cernea et al.
77
stated that injury to the external branch of the superior 
laryngeal nerve will most likely endure, causing a permanent voice change for 
professional singers. Fatigue, also is common after injury to the external branch of 
the superior laryngeal nerve. Cernea et al. advised nerve identification in the 
operating room, especially for patients with large goiters.  
In most patients, the blood vessels lie within the visceral compartment of 
the neck, beneath the pretracheal fascia. The external laryngeal nerve is an 
exception lies between the fascia and the inferior pharyngeal constrictor muscle.  
There is thus a plane of dissection between the vessels and the nerve. In about 25 
percent of individuals, the nerve lies beneath the fascia together with the vessels.
80 
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HISTOLOGY 
The thyroid gland is surrounded by the thyroid capsule, which is a thin 
layer of connective tissue. From the capsule, several septa extend within the 
thyroid parenchyma, dividing it further into several lobules. Epithelial cells either 
cuboidal or squamous form the thyroid follicles. They are separated by thin 
connective stroma which is rich in both lymphatic and blood vessels. Small 
bundles of nerves are present. 
 
There is a colloidal gelatinous collection in the center of the  follicle. Each 
follicle has two types of cells: follicular and parafollicular, or C cells. 
 
According to Ross and Reith, the follicular cells are responsible for  the 
following actions: 1) synthesis of thyroglobulin 2) iodination 3) storage of 
thyroglobulin, 4) resorption of thyroglobulin, 5) hydrolysis of thyroglobulin, and 
6)release of thyroid hormone into the blood and lymphatics. 
 
The parafollicular cells or C cells, can be found in the connective stroma 
between the follicles or in the follicular epithelium. Characteristically, they 
contain several secretory granules. 
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Histology of Thyroid Gland 
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PHYSIOLOGY 
 The thyroid gland weighs 10 to 20 g in normal adults and is responsible for 
the production of two families of metabolic hormones, the thyroid hormones, 
thyroxine (T4) and triiodothyronine (T3), and the calcium-regulating hormone, 
calcitonin. The spherical thyroid follicular unit is the important site of thyroid 
hormone production. The follicular unit is made up of a single layer of cuboidal 
follicular cells that encompass a central depository of colloid filled mostly with 
thyroglobulin (Tg).  Thyroglobulin is the protein in which T4 and T3 are 
synthesized and stored. 
Iodine Metabolism 
Iodine is essential for the production of thyroid hormones. It can be 
efficiently absorbed from the gastrointestinal (GI) tract, in the form of inorganic 
iodide and rapidly enters its extracellular iodide pool. The thyroid gland is 
responsible for storing 90% of total body iodide at any given time, with less than 
10% existing in the extracellular pool. Iodide is stored in the thyroid as preformed 
thyroid hormone or as an iodinated amino acid. Iodide is transported from the 
extracellular space into the follicular cells against a chemical and electrical 
gradient via an intrinsic transmembrane protein located in the basolateral 
membrane of the thyroid follicular cells. Once inside the cells, iodide rapidly 
diffuses to the apical surface, where it is quickly moved to exocytic vesicles. Here, 
it is rapidly oxidized and bound to Tg. Transport of iodide into follicular cells is 
regulated by thyroid- stimulating hormone (TSH) from the pituitary gland, as well 
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as by the follicular content of iodide. The relationship between iodine ingestion 
and thyroid disease has been known for more than 100 years.  At the turn of the 
20th century, the practice  of  iodine supplementation  of  food and water came 
about as a result of careful study in areas in which iodine insufficiency was found 
and linked to endemic goiter. Significant iodine deficiency still occurs in various 
undeveloped parts of the world. In situations in which iodine excess occurs, 
disorders such as Graves’ disease and Hashimoto’s thyroiditis can occur. 
Thyroid Hormone Synthesis 
Once organic iodide is efficiently oxidized and bound, it couples to Tg 
with tyrosine moieties to form iodotyrosines in a single conformation 
(monoiodotyrosine [MIT]) or a coupled conformation (diiodotyrosine [DIT];). 
The formation of DIT and MIT is dependent on an important intracellular 
catalytic agent, thyroid peroxidase. This enzyme, along with TG  is remarkably 
specific to the thyroid follicular cells, making both important in the diagnosis and 
management of autoimmune thyroid disease and well differentiated thyroid 
cancer. MIT and DIT are biologically inert. Coupling of these two residues gives 
rise to the two biologically active thyroid hormones, T4 and T3. T4 is formed by 
the coupling of two molecules of DIT, whereas T3 is formed by the coupling of 
one molecule of MIT with one molecule of DIT. In normal circumstances, 
formation of T4 predominates. Both T3 and T4 are bound to Tg and stored in the 
colloid in the center of the follicular unit. 
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Diagrammatic scheme of thyroid hormone formation and secretion. 1, Tg 
and protein synthesis in the rough endoplasmic reticulum. 2, Coupling of the Tg 
carbohydrate units in the smooth endoplasmic reticulum and Golgi apparatus. 3, 
Formation of exocytotic vesicles. 4, Transport of exocytotic vesicles with 
noniodinated Tg to the apical surface of the follicle cell and into the follicular 
lumen. 5, I odide transport at the basal cell membrane. 6, Iodide oxidation, Tg 
iodination, and coupling of iodotyrosyl to iodothyronyl residues. 7, Storage of 
iodinated Tg in the follicular lumen.8, Endocytosis by micropinocytosis.9, 
Endocytosis by macropinocytosis (pseudopods).10, Colloid droplets.11, Lysosome 
migrating to the apical pole. 12, Fusion of lysosomes with colloid droplets. 13, 
Phagolysosomes with Tg hydrolysis. 14, T3 and T4 secretion.15, MIT and DI T 
deiodination. 
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Most thyroid hormone released from the thyroid gland is T4, which is 
deiodinated in peripheral extrathyroidal tissues and converted to T3. Release of T4 
and T3 is regulated by the apical membrane of the follicular cell via  lysosomal 
hydrolysis of the colloid that contains the Tg-bound hormones. The apical 
membrane of the thyroid cell forms multiple pseudopodia and incorporates Tg into 
small vesicles, which are then brought into the cell apparatus. Within the vesicles, 
lysosomal hydrolysis results in the reduction of the disulfide bonds and T3 and T4 
are then free to pass through the basement membrane and be absorbed into the 
circulation, where more than 99% of each hormone is bound to serum proteins. 
Although sensitive assays of peripheral blood can measure Tg, peripheral Tg 
represents an extremely small fraction of total body stores. Residual iodotyrosines 
undergo peripheral breakdown, deiodination, and recycling and can then be added 
to the recently absorbed iodide stores and become available for the synthesis of 
new thyroid hormone. 
Thyroglobulin 
Tg is a 660-kDa glycoprotein specific to the follicular cell that is the 
primary component of the colloid matrix necessary for iodination and 
hormonogenesis. Tg facilitates the conversion of MIT and DIT into T3 and T4. 
This process is accompanied by the escape of small amounts of Tg into the 
peripheral bloodstream, where it can be assayed. TSH enhances the whole process 
of endocytosis, proteolysis, and release through an adenylate cyclase system. 
Excess peripheral levels of iodine inhibit further release by enhancing Tg 
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resistance to proteolysis. Peripheral Tg can be measured to evaluate benign or 
malignant thyroid neoplasms. Measurement of peripheral Tg has predictive value 
for the recurrence of well-differentiated thyroid carcinoma, locally or in metastatic 
deposits after initial total thyroidectomy 
Calcitonin 
 Calcitonin is a 32–amino acid polypeptide secreted by the parafollicular 
cells, or C cells, located superolaterally in each thyroid lobe. Calcitonin acts 
principally, to inhibit calcium absorption by osteoclasts and thereby to lower 
peripheral serum calcium levels. Increased peripheral levels of serum calcium 
stimulate calcitonin secretion. Calcitonin secretion can be stimulated clinically by 
the infusion of calcium, pentagastrin, and alcohol. The specific action of calcitonin 
takes place on the surface receptors of osteoclasts but its effect does not result in a 
clinically apparent marked decrease in calcium levels. Basal or stimulated 
calcitonin levels are sensitive markers for primary or recurrent MTC.  
Regulation of Thyroid Hormone Secretion 
The hypothalamic-pituitary-thyroid axis regulates thyroid hormone 
production and release in a classic endocrine feedback system. The major regulator 
of thyroid gland activity is the glycoprotein TSH, which is a major growth factor 
for the thyroid. TSH stimulates thyroid cell growth and differentiation, as well as 
iodine uptake and organification and release of T3 and T4 from Tg. Also, TSH has 
been shown to stimulate the growth and invasive characteristics of some well-
differentiated thyroid cancer cell lines in vitro. TSH is a 28-kDa glycoprotein 
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secreted in a pulsatile fashion by the anterior pituitary gland. It has two 
components; the α subunit is common to other anterior pituitary hormones but the 
β subunit is unique to TSH and determines the hormone’s biologic specificity. The 
receptors that respond to TSH have been identified and cloned. Specific mutations 
in the genetics of this system have been identified and are associated with 
follicular thyroid neoplasms. 
The feedback loop is an important regulator of TSH secretion. Increased 
thyrotropin-releasing hormone (TRH) from the paraventricular nucleus of the 
hypothalamus and reduced levels of T3 stimulate release of TSH from the anterior 
pituitary. Peripheral thyroid hormone levels may, in addition to stimulating release 
of TSH from the anterior pituitary, enhance TRH secretion. Peripheral T4 is locally 
deiodinated in the pituitary and converted to T3, which then directly inhibits the 
release and synthesis of TSH. The condition that usually decreases TSH secretion 
is classified as primary hyperthyroidism. It has many causes, including many types 
of thyroiditis, Graves’ disease, autonomously functioning thyroid nodules, and 
conditions that increase human chorionic gonadotrophin (hCG) levels, such as 
gynecologic malignancies and overuse of exogenous thyroid hormone. 
Decreased levels of TSH can also be caused by abnormalities at the level of 
the pituitary and/or hypothalamus, which are collectively termed central 
hypothyroidism. These conditions are much rarer than primary hyperthyroidism.  
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Although TSH is the primary regulator of thyroid hormone synthesis, 
intrinsic autoregulatory mechanisms are alternative routes whereby the thyroid can 
control intraglandular stores of thyroid hormones. In areas in which dietary iodide 
is excessive, the thyroid gland has an autoregulated process that inhibits the uptake 
of iodide into follicular cells. The reverse is true in iodide deficiency. Excessively 
large doses of iodide have complex effects. These include an increase in 
organification followed by cessation of production, a syndrome known as the 
Wolff- Chaikoff effect. 
Peripheral Action of Thyroid Hormones 
In the periphery, T3 is significantly more potent than T4. Most T4 is 
converted to T3, which has a high affinity for the peripheral nuclear thyroid 
hormone receptor (TR), a member of the steroid hormone receptor family. 
Therefore, the action of thyroid hormones in the periphery consists predominantly 
of the interaction of T3 with the nuclear TR, which then binds to regulatory 
regions in various gene-regulated processes. Two genes regulate TR production 
and activity, the α and β forms, which are located on chromosomes 17 and 3 . The 
β form of TR is contained within the liver; the central nervous system contains 
predominantly an α form of TR. The clinical result of thyroid hormone action is 
regulated through TR and its effect on various genes, expressions of which are 
then regulated in the nucleus via the production of polypeptides. For example, T3 
acts on the pituitary by regulating transcription of the genes for the α and β 
subunits of TSH, which results in TSH secretion. T3 affects cardiac contractility 
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by regulating the transcription of myosin heavy chain production in cardiac muscle. 
Of circulating T3 and T4, 80% is bound to thyroxinebinding globulin (TBG) in the 
periphery. A number of medications and clinical scenarios alter serum levels of 
TBG or the affinity of TBG for circulating thyroid hormone. 
 
 
 
 
 
 
 
 
Fig-15. Cellular and molecular events involved in thyroid hormone 
function 
Also, T4 is bound to prealbumin and albumin. In pregnancy and other 
clinical situations with elevated estrogen levels, such as oral contraceptives, 
menopausal estrogen replacement therapy, and tamoxifen or raloxifene use 
(selective estrogen receptor modulators), TBG levels are significantly increased, 
thereby resulting in higher levels of bound T4 (total) in the periphery. Other causes 
of increased TBG concentrations include heroine or methadone use, clofibrate, and 
5-flurouracil (chemotherapeutic agent). In contrast, decreased TBG levels are 
caused by agents such as anabolic steroids (testosterone), nicotinic acid, and 
corticosteroids. 
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Such states are clinically euthyroid, however, because free T4 levels are not 
altered. Most T3 and T4 are bound to the extent that free T4 constitutes less than 
1% of peripheral hormone. The bound form of thyroid hormone cannot pass from 
the extracellular space and must be in the free form to diffuse into extracellular 
tissues to affect major metabolic activity. T3 is especially important in this regard. 
Most T3 is peripherally derived from the deiodination of T4, which takes place 
largely in the plasma and liver. Other deiodination processes are found in the 
central nervous system, especially the pituitary gland and brain tissues, as well as 
in brown adipose tissue. Peripheral conversion of T4 to T3 can be impaired in 
many clinical circumstances, such as overwhelming sepsis and malnutrition, 
thionamide (propylthiouracil) use, high- dose corticosteroids, beta blockers, 
iodinated contrast agents, and amiodarone use. The half-life of T3 is 
approximately 8 to 12 hours and free levels disappear rapidly from the peripheral 
circulation. In adults, the half-life of T4 is approximately 7 days because of the 
efficient and significant degree of binding to carrier proteins. 
Inhibition of Thyroid Synthesis 
Drugs Antithyroid medications are an option for the treatment of thyroid 
excess states. The thionamide class of antithyroid drugs includes propylthiouracil 
(PTU) and methimazole. This class of drugs acts by inhibiting the organification 
and oxidation of inorganic iodine, as well as by inhibiting linkage of the initial  
iodotyrosine molecules MIT and DIT. In addition to these effects, PTU inhibits the  
  
40 
 
peripheral conversion of T4 to T3.Because of this added capability, PTU is a 
popular choice for the rapid treatment of hyperthyroid conditions. 
Methimazole has longer activity and requires a single daily dose; it is the 
preferred agent in nonpregnant individuals. Both drugs can cause agranulocytosis 
but this occurs in less than 1% of cases. Other side effects include rash, arthralgias, 
neuritis, and liver dysfunction (potentially worse with PTU). Exogenous 
glucocorticoids can effectively suppress the pituitary-thyroid axis. Also, they can 
act in the periphery to inhibit the peripheral conversion of T4 to T3. This 
effectively lowers serum T3 levels, thus allowing steroids to be used as a rapid 
inhibitory agent for hyperthyroid conditions. Steroids can also lower serum TSH 
concentration. The rapid action of steroids makes them a potentially important 
primary treatment of severe, previously untreated, or resistant hyperthyroidism; 
however, they are not without potential side effects. 
Patients with thyrotoxicosis have increased adrenergic stimulation. 
Although beta blockers do not directly inhibit thyroid hormone synthesis per se, 
they are valuable in controlling peripheral sensitivity to catecholamines by 
blocking their effects. Iodine, given in large doses after the administration of an 
antithyroid medication, can inhibit thyroid hormone release by altering the organic 
binding process (Wolff- Chaikoff effect). This stunning effect is transient, but 
iodine supplementation can be used to treat hyperactivity of the gland in 
preparation for surgery. 
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EPIDEMIOLOGY AND INCIDENCE 
Disorders of thyroid including the ‘Solitary nodule’ occur worldwide, their 
incidence varying from high in Switzerland, the Andes and India to low 
population and the intensity and duration of goitrogenic stimuli to which 
population is subjected. palpable thyroid nodule in Euthyroid individual is 
common in clinical practice occurring upto 4% of general population, their 
incidence increase with age.  
In contrast, however, a true solitary thyroid nodule, accounting for up to 
approximately 25% of clinically detectable solitary thyroid nodule is important 
both clinically and pathologically since although most of the case turn out be 
benign, 10-30% will harbour malignant neoplasm . The incidence of malignancy in 
solitary nodule who undergo surgery is increasing chiefly due to improved 
selection of patients for surgery. 
SEX INCIDENCE: 
Thyroid disorders are preponderantly confined to females in the ratio of 6:1 
and this is due to variations of thyroid hormone demand during female 
reproductive function, physiological events such as puberty, pregnancy, lactation. 
Incidence of solitary nodules is also higher in females. Bhansali
84
 has reported F:M 
ratio of 7:2 and Kapur
85 2:1 But incidence of Malignancy in solitary nodule is 
more in men (26%) compared to female (9%). 
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AGE INCIDENCE: 
 Thyroid nodules occur at all ages, the reported age range from 15-69 years 
with maximum incidence in 30-40 years. Solitary nodule is rare in children, the 
incidence of carcinoma in such a nodule under 25 years of age is about 50% and 
75% in patient under 15 years. 
INCIDENCE OF MALIGNANCY IN SOLITARY NODULE OF 
THYROID 
Though commonest cause of solitary nodule is not carcinoma, a significant 
proportion is carcinomatous. In general between 10-20% of solitary nodule 
removed surgically is malignant. 
Solitary nodule found in thyroid of patient less than 20 years and greater 
than 60 years carries far greater risk of being malignant. 
CAUSES OF SOLITARY THYRIOD NODULES  
I. Colloid (Adenomatiod) Nodule 
II. Thyroid 
adenoma 
Follicular 
adenoma 
Hurtle 
adenoma 
Papillary 
adenoma 
III. Thyroid cancer 
IV. Primary 
I. Papillary carcinoma 
43 
 
II. Follicular carcinoma 
III. Hurtle cell carcinoma 
IV. Medullary carcinoma 
V. Anaplastic carcinoma 
A. Metastatic /Direct invasion 
A. Renal cell carcinoma  
B.  Gastric carcinoma 
C. Breast carcinoma 
D. Pancreatic carcinoma. 
E. Lung carcinoma 
F. Head and neck tumors 
G. Melanoma  
H. Hodgkin’s disease 
I. Colon carcinoma 
 Thyroid cyst 
 Thyroiditis 
 Acute 
 
 Sub acute or De Quervan’s thyroiditis 
 
 Hashimoto’s 
 
 Riedel’s thyroiditis 
 
 Infections 
o Abscess 
 
o Tuberculosis 
 
 Inflammatory 
o Sarcoidosis 
 
o Amyloidosis 
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 Developmental abnormalities 
o Thyroid hemiagenesis 
o Teratoma 
 
DIFFERENTIAL DIAGNOSIS OF SOLITARY NODULE OF  
THYROID 
 
o Thyroglossal duct cyst 
 
o Lipomas 
 
o Extrathyroidal haematoma 
 
o Oesophageal diverticulum 
 
o Parathyroid adenoma, cyst or carcinoma 
 
o Pre and paratracheal lymphnodes. 
 
 Solitary  nodule  of  thyroid  can  arise from   diverse  causes. 
The common causes of solitary thyroid  nodules  are  adenomatous  goiter,  
neoplasms  and chronic thyroiditis. In practice, a  clinical  diagnosis  of  solitary  
thyroid  nodule  is, in fact, a dominant nodule of multinodular goiter is 50% of 
cases, as shown on subsequent investigations  any dominant   nodule  within a  
multinodular  goiter  should be essentially treated as  solitary  thyroid  nodule, as  
they  have  incidence  of malignancy of   around 10%. 
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ETIOLOGICAL FACTORS 
 Etiology of adenomatous nodules 
Adenomatous goiter occur as a result of compensatory mechanism against 
deficient synthesis of thyroid hormone by the thyroid gland. The hormone by the 
thyroid follicles is regulated by TSH, secreted by anterior pituitary which in turn is 
regulated by negative feedback mechanism by the levels of thyroid hormone in 
blood and by TRH sercreted by hypothalamus. When there are low levels of T3 
and T4 in blood they stimulate anterior pituitary to secrete TSH , which acts on 
follicular cell, induces hyperplasia, and hypertrophy to trap iodine and synthesis 
more of T3 andT4 . The hyperplasia may not occur uniformly, several foci of 
hyperplasia may result, of which some are large, some small. Following 
hyperplasia there is involution after need for T3and T4  decrease.  Repeated 
stimulation of thyroid causes hyperplasia and involution of varying degrees end 
also degenerative changes and fibrosis resulting in nodularity. If among various 
nodule only one of them attain large size which cannot be detected clinically, a 
solitary adenomatous nodule ensues. 
Iodine deficiency in endemic area results in endemic area results in highest 
incidence of goiter and greater than 50% prevalence is found in extreme iodine 
deficient area. 
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 ETIOLOGY OF THYROID NEOPLASMS: 
a)  Radiation: The relationship between ionizing radiation and development 
 of benign adenomas and malignant tumors is well known. Thyroid 
 exposure  to radiation can occur in two ways. External and Internal 
 Sources. External exposure can  be because of  medically administered  
 external  beam radiation or environmental exposure previously related to 
 nuclear weapons attack or weapons testing  and  more  recently  nuclear 
 power plant accidents. 
Internal ingestion of isotopes  of  iodine  which  is  concentrated in the  
thyroid gland can come from the fallout from nuclear weapons, or from  ingestion  
of  the isotopes from  the  fallout  from  nuclear weapons,  explosion or power 
plant accidents . 
The carcinogenic radiation is by 2 mechanisms 
1. Cellular injury with altered cell division and replication of nucleic acids. 
2. The injured cells produce less thyroid hormone leading to TSH stimulation 
which is itself radiation exposure include: 
a) Amount of radiation received 
b) Duration of radiation received 
c) Age at which radiation was received 
d) Latent period 
Low dose radiation for Tinea capitis (6-5 cGy), thymic enlargement (100 
to400 cGy), enlarged tonsils and adenoids (750Egy) Acne vulgaris (200 to 1500 
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cGy)  are best known  etiological  factor  . The risk  increases  linearly  from  6.5 
to  2000 cGy, beyond which the incidence decline as radiation  causes  destruction  
of  thyroid  tissues. The risk maximum 20 to 30 years after exposure. 
Approximately 30% of exposed children develop thyroid nodules and  of  these  
estimated  30%  are malignant 
b) Ingestion of radioisotopes and malignancy 
The most common exposure is due 131 I administered for diagnostic thyroid 
scans. A typical scan exposes the thyroid to approximately 50 rads of external 
beam radiation. Studies have shown that is only a small increase  in  the of 
incidence  of  malignancies  of  thyroid  after  exposure  to  this dose. 
A more dangerous type of ingestion of radioisotopes comes from exposure 
to nuclear fallout. Contrary to medically administered 131 I and short lived radio - 
isotopes such as 129 I and 131-135 I. 
Vast majority of patients developing post radiation malignancy have 
papillary histology. 
c) Diet 
There is an increased incidence of follicular cancer in iodine deficient 
endemic goiterous  areas  as well  as an  papillary  carcinoma  in  iodine  rich 
regions. 
d) Sex: 
Factors such as parity, early menopause, contraceptive use and late age at 
first birth in female population have been reported to have increased risk of 
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thyroid carcinoma but the data been inconsistent. 
The thyroid nodule is more likely to be a cancer in men than in men than in 
women and in young (under 20 years) and older (over 60 years) patients rather 
than others. 
e) Genetic predisposition: 
There is no clear familial syndrome or genetic dis ease associated with non-
medullary thyroid carcinoma. Loose associations with familial polyposis of colon 
including Gardner’s syndrome, Cowden’s syndrome, melanomas, testicular and 
bladder cancer have been reported. This contrasts with medullary thyroid 
carcinoma, which has a variety of genetic syndromes now being defined at  
molecular  levels. The familial medullary carcinoma syndromes is transmitted as 
an autosomal dominant trait and thus 50% of the offspring would   be  expected  to  
have  this disease 
d) Aetiology of chronic thyroiditis (Hashimoto’s thyroiditis): 
Hashimoto’s thyroiditis is clearly autoimmune in nature and may be  the 
most common autoimmune disorder as well This occurs as a painless diffuse  
goiter in young or middle age women and often presents as an  incidental  finding 
during routine  physical examination 
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PATHOLOGY 
1) Colloid (Adenomatoid) nodule 
This goiter is mainly due to stimulation with increased TSH. TSH secretion 
is increased due to low level of circulating thyroid hormones. Simple goiter are 
more common in females than in males owing to the presence of estrogen 
receptors in thyroid tissue. 
Persistent growth stimulation causes diffuse hyperplasia, all lobules are 
composed of active follicles and iodine uptake is uniform. If TSH stimulation 
ceases, the goiter may regress. The goiter is soft diffuse and may become large 
enough to cause discomfort. A colloid goiter is a late stage of diffuse hyperplasia 
when TSH stimulation has fallen off and follicle are inactive and  full of colloid. 
Latter as a result of fluctuating stimulation of TSH, a mixed pattern 
develops with areas of active lobules and areas of inactive lobules. Active lobules 
become more vascular and hyperplastic until hemorrhage occurs, causing central 
necrosis and leaving only a surrounding rim of active follicle. Necrotic lobules 
coalesce to form nodules filled either with iodine – filled colloid or mass of new 
but inactive follicles. 
Continual repetition of this process result in a nodular goiter. Most nodules 
are inactive and active follicles are present only in the internodal tissue 
Nodules are usually multiple forming a multinodular goiter. A toxic 
multinodular goiter usually develops in a large, long standing multinodular goiter  
of  atleast 10 year duration, only one macroscopic nodule is found but  
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microscopic  changes  will be present throughout the gland, this is one form  of  
clinically  solitary  nodule. Nodules may be  colloid,  cellular  and  cystic  
degeneration  and  haemorrhage  are  common as is  subsequent calcification. 
Adenomatous nodule 
Appear like a circumscribed nodule  of varying length. Commonly  undergo 
cystic change .Focal areas of fibrosis and hemorrhage may be seen. 
Microscopically nodules are cluster of active looking follicles with focal areas of 
colloid cysts and hemosiderin laden with macrophages. 
Toxic  adenomatous nodule 
On histological examination, large and small follicels lined by columnar 
and tall cubodial epithelical cell are alternatively formed. 
2. Thyroid adenoma 
Usually presents as a asymptomatic solitary nodule or with large mass with 
local symptoms Microscopically slow growing encapsulated solitary nodule with 
uniform histological architecture within the capsule. Areas of focal necrosis, 
hemorrhage  may occur as retrogressive changes: It needs to be differentiated with 
MNG  produce less compression of adjacent thyroid parenchyma and lack a well 
formed capsule. With evidence of vascular invasion and capsular invasion one 
should rule out Follicular carcinoma. 
  
51 
 
Adenomas can be classified into 
• Follicular adenoma and its variants 
• Papillary adenoma 
• Atypical adenoma 
a) Follicular adenoma: 
Almost all thyroid adenoma show follicle formation to a varying degree; 
follicle adenoma are usually but may contain a variable amount of colloid; It is 
unknown whether follicular adenomas show transition over time to malignancy. 
Further investigations may be needed differentiate from follicular carcinoma 
 According to  the  size  of  follicles  and  the  degree  of  follicle  
formation, follicular adenomas  are  further  classified as i) Colloid  ii) Simple                
iii) Fetal iv) Hurthle cell v) Embryonal   
III) Malignant neoplasms of thyroid
82
:  
Classification of malignant neoplasm of thyroid: 
a) Well differentiated thyroid carcinoma; 
i) Papillary carcinoma. 
ii) Follicular carcinoma. 
b) Poorly differentiated thyroid carcinoma; 
i) Hurthle cell carcinoma. 
ii) Variants of papillary carcinoma: 
-Tall  cell variant. 
-Insular variant. 
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-Columnar variant. 
c) Medullary carcinoma. 
d) Undifferentiated (Anaplastic) carcinoma 
a) Well differentiated thyroid carcinoma: 
i)  Papillary  carcinoma  of  the  thyroid  
82
:   
Papillary  carcinoma  is  the most common thyroid carcinoma in both 
children and adults with incidence of 62%. It frequently presents in 4
th and 5
th 
decades  with  male  to  female  ratio  of 1:3. Multicentric tumour with lymphatic 
spread of primary tumour. Papillary carcinoma is associated with excellent  
prognosis  (10  years survival rate  is 95%). 
Micro: Histologic diagnosis is made on the basis of papillary architecture or 
characteristic nuclear features. True papillae have  fibrovascular  core  and are 
generally lined by single  row  of  epithelial cells. Orphan Annie nucleus is 
characteristic. Sometimes occult malignancy may spread to lymph node causing 
isolated lymphnode enlargement( Lateral Aberrant Thyroid)   
ii) Follicular carcinoma82: 
 
It is the next most common thyroid carcinoma comprising 20-25%, 
incidence is less in iodine sufficient areas.  They occur more commonly in women 
(F:M= 2.6:1), most often in middle aged or older individual. More aggressive 
tumour. While lymph node metastasis are unusual, a significant number of patients 
initially present with or subsequently develop distant metastasis. 
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Micro: Follicular carcinoma have a range of pattern similar to those found in 
follicular adenomas. Pleomorphism is not marked. Capsular and vascular invasion 
are characteristic. They may be i) encapsulated or minimally invasive carcinoma        
ii) widely invasive carcinoma 
The prognosis of patient with encapsulated minimally invasive carcinoma 
is much better than for those with widely invasive carcinoma. It is found that 
metastasis developed in 2-3% and 25% of patient with minimally and widely 
invasive carcinoma respectively and cumulative death rate at 10 years was 3% and 
32% respectively  
Regional lymph node metastasis is unusual and distant metastases are much 
more common usually to be bone, lungs via hematogenous route 
a) Poorly differentiated carcinoma 
b) Hurthle  cell  carcinoma
82
: Hurthle  cell   carcinoma  accounts  for  3%  of all 
thyroid  malignancies  is  a  subtype  of follicular carcinoma that closely 
resembles follicular carcinoma. This occurs in older persons usually  60-70years  
of  age. The tumor contains an abundance of oxyphilic cells  or  oncocytes under 
interpreted  as  nodular hyperplasia. 
c) Medullary carcinoma  
Medullary carcinoma accounts for 5 to 10% of thyroid malignancies. The 
malignancy involves the para-follicular cell  or  “c” cell derived  from  neural 
crest. This can occur in  sporadic  form  (non- familial) (80%)  or  as  a  part  of  
MEN type 2A  or  2B,  Sporadic  cases  are  more  common  in  women  while  
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familial  cases are autosomal dominant and affect both sexes equally. In sporadic 
cases, the lesion usually within one lobe where as men involves upper halves of 
both lobes. 
Medullary thyroid tumors secrete not only calcitonin and carcino-
embryonic antigen (CEA) but also calcitonin gene related peptide (CGRP), 
histaminadases, prostaglandins E2 and F2a and serotonin. The calcitonin excess is 
not associated with hypocalcemia. The presence of both a mass and an elevated 
calcitonin level is diagnostic of medullary carcinoma. Calcitonin is more sensitive 
tumor marker but CEA is a better predictor of prognosis. Screening for 
pheochromocytoma with 24 hour urinary catecholamines is mandatory in any 
patient whose thyroid mass is suspected as being medullary thyroid carcinoma. 
Medullary carcinoma invades locally and gives rise to metastsis in cervical 
and mediastinal lymph nodes(50%) and also in distant organs (15-25%) 
particularly in lung, liver and skeletal system. 
Micro: The classic presentation is represented by a solid proliferation of round to 
polygonal cells of granular amphophilic cytoplasm and medium sized nucleus, 
separated by a highly vascular stroma, hyalinized collagen and amyloid. The 
nuclei resemble those of neuroendocrine tumours in other areas of body. They are 
usually round and stippled “pepper and salt” chromatin. 
d) Anaplastic carcinoma
82,83
: 
Anaplastic thyroid carcinoma represent less than 1% of all thyroid 
malignancies. This occurs in 7
th or 8
th decade. It is most aggressive from with 
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dysphagia, cervical tenderness and painful neck mass. Superior  venacava 
syndrome can  also  be  part  of  presentation  regional  lymph  nodes are  
frequently enlarged. Distant  metastases  to  lungs  and  bones  are  common 
e) Lymphomas 
Lymphomas account for less than 1% of thyroid malignancies and most  are 
of the  non-B-cell type. 
iv)  Thyroid cyst: About  50% of  cystic  swelling are idiopathic . FNAC is done 
as therapeutic and diagnostic procedure. USG may be used to identify suspicious 
cysts. Reaccumulation is common. Few may need surgery. 
v) Thyroiditis:  
Includes the following types namely: 
1. Chronic lymphocytic thyroiditis (Hashimoto thyroiditis). 
2. Sub-acute lymphocytic thyroiditis or Post-partum thyroiditis. 
3.Sub acute granulomatous thyroiditis (de-Quervain’s thyroiditis). 
4. Acute suppurative thyroiditis. 
5. Invasive fibrous thyroiditis(Riedel’s thyroiditis). 
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TNM STAGING 
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Workup of a solitary thyroid nodule 
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INVESTIGATIONS 
ROUTINE INVESTIGATIONS 
As in other general surgical cases, routine investigations like blood analysis 
(Hb%, BT, CT), urine analysis, radiological assessment of chest are done to assess 
the fitness of the patient to undergo major surgical procedure. 
SUPPORTIVE INVESTIGATIONS 
1. ECG: In hypothyroid state, low voltage, flattened ST wave or inversion of 
T waves are seen. In hyperthyroidism sinus tachycardia, atrial tachycardia, 
atrial fibrillation and signs of left ventricular hypertrophy may be seen. 
2. Serum cholesterol: In hypothyroidism, it is markedly increased (more than 
300 mg%). 
3. Indirect laryngoscopy: Routine laryngoscopic examination should be 
made before thyroidectomy. Pre-operative detections of vocal cord 
paralysis is essential. It also helpful in diagnosing involvement of recurrent 
laryngeal nerve. 
4. Radiological investigation: Radiography of neck is helpful in 
determining the position of trachea, retrosternal extension and also 
calcification in the nodule. Calcification is seen in long standing 
adenomatous goiter and papillary carcinoma and extensive calcification in 
nodular goiter. 
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SPECIFIC INVESTIGATIONS 
5) Tests for thyroid function: 
Most of the patients with solitary thyroid nodule are euthyroid, but 
laboratory confirmation of this is generally agreed that no single procedure, 
consistently yields reliable basis for diagnosis and therefore, a combination of 
various tests are generally required. 
i) Thyroid function tests: 
 The most useful index of thyroid function is the direct measurement 
of circulating thyroid hormones. Total T4 and total T3 are designated T4 and 
T3 respectively. These are measured by radioimmune assays. 
Normal values : T4 : 55-155 nmol/lit  ,T3 : 1-nmol/lit.,   
  
ii)  Free thyroid hormone measurements: 
 FT4 can be measured by two methods: equilibrium dialysis or radio 
immunoassay (RIA).  Dialysis  methods  is  the  gold   standard is restricted  to  
research laboratories as it is time consuming and only a small number of samples 
can be processed. Simultaneously ft4 measurements by RIA is valuable and it 
provides an excellent index of thyroid status in almost any clinical situations. 
Normal FT3 is 1.3-3.5 nmol/l and FT4 is 170-160 nmol/l (12-28 pmol/l). 
iii) Serum thyroid stimulating hormone (TSH): 
Another very sensitive test of thyroid function is the serum TSH value. 
This is measured by immunoassay technique. The normal serum TSH level is 
0.3-5miu/l. It is raised in primary hypothyroidism (may be over 40 miu/l) and 
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almost undetectable in hypothyroidism. It is the most sensitive test of primary 
hypothyroidism. 
iv) Radioiodne uptake (RAIU) test: 
 
Routine isotope scanning has been abandoned except when toxicity is 
associated with nodularity. It is used delineating the presence , size and function 
of thyroid nodules. I
131 (half life of 8 to 10 days, dose of 5 mCi)is used for distant 
metastasis screening in well differentiated thyroid carcinoma. Depending upon 
uptake a) Hot nodule (hyperfunctioning) (5%). b) Warm or neutral nodule (10-
15%). The incidence of malignancy in 9%.c)Cold nodule (hypo functioning) (80-
85%). The incidence of malignancy is 15- 20%. 
6) Ultrasonography: Ultrasound is a simple, rapid, relatively cheap and 
noninvasive method to study the structure of thyroid. High resolution 
ultrasonography (7.5 to 10 MHz) is used. It can pick up  impalpable  nodules as 
small as  0.3 cm in diameter. USG is useful in distinguishing between solid and 
cystic lesions, malignant and benign lesions. FNAC can also be taken under USG 
guidance.  Benign lesion  nodule shows “hallow sign ” on USG and features 
suggestive  of  malignancy  include hyperchoic pattern in complete peripheral 
halo, irregular  margins  and microcalcifications. 
7) Computerized tomography and magnetic resonance imaging: 
There is no place for CT scanning and MRI in routine evaluation except to 
determine the extent of a large cervical or retrosternal thyroid and spinal 
metastases . 
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8) Tissue diagnosis: 
a) Fine needle aspiration cytology (FNAC): 
FNAC  is a  highly accurate and cost effective diagnostic technique of 
low morbidity  providing  a  valuable  to clinical assessment in overall selection 
of patients with  thyroid  nodules  for surgery. The  sensitivity  of  FNAC  for  
detection  of  malignant  lesions  is approximately 83% and the specificity is 
about 92%. Problems with FNAC include difficulty in  
* Follicular lesions (benign Vs malignant). 
* Hurthle cell lessions (benign Vs malignant). 
*Lymphocytic   lesions  ( lymphocytic  thyroiditis Vs lymphoma) 
b) Core needle biopsy:  
 Only indicated in  Lymphoma and Hard fixed thyroid swelling in 
conclusive with FNAC, otherwise not routinely indicated 
9) Serum Thyroglobulin (Tg): Normal levels 1-43 ng/ml. 
Used in the post operative follow up after total thyroidectomy to indicate 
recurrences ( Tg> 10 ng/ml) 
10) Serum Calcitonin: 
Calcitonin hormone secreted by para-follicular C-cells serves as useful 
marker in detection and follow up of medullary carcinoma.  
11) Measurement of antibodies: 
About 95% of patients with Hashimoto’s thyroiditis and 80% with 
Grave’s disease have detectable anti-microsomal antibodies. 
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TREATMENT 
The optimal  management of  the  solitary  nodule  of  thyroid  continues  to  
be a source of  controversy  and  operative  intervention  recommended  by  most  
surgeons. Though the majority of nodules are benign, a significant proportion 10-
30%, are malignant carcinoma of thyroid. The   common  indications for surgery 
in a solitary nodule are as follows : 
1. Pressure effects irrespective of aetiological diagnosis  
2. Malignancy  
3. Cosmesis  
The treatment for different aetiological entities  
1] Adenomatous non–toxic nodules 
 As the basic cause is diminished synthesis of thyroxine should be treated 
by thyroxine replacement therapy (0.1- 0.2 mg /day) with periodic montoring of 
nodule regression and serum levels of T3, T4 and TSH be measured at regular 
intervals. Surgery  (Hemithyroidectomy)is indicated for the above mentioned 
reasons and post op thyroxine replacement is given. 
2] Lymphocytic thyroiditis: 
 It eventually result in hypothyroidism, treatment is essentially conservative 
with; oral thyroxine substitution therapy by monitoring the serum levels of T3, T4, 
TSH.  Surgery is indicated  for pressure effects  by  a large  nodule  or  for 
cosmesis. 
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3) Toxic nodule: 
It is an autonomously functioning thyroid nodule that  produces 
hyperthyroidism. Toxic nodule can be  treated  by  surgery after making patient 
euthyroid  or  by radioactive  iodine therapy. 
4) Thyroid cyst: 
About 15% of all thyroid nodules are cystic.  Majority  of  them  (97%) are  
benign. FNAC and USG of neck are the common investigations done. Presence of 
solid remnants warrants to rule out malignancy Simple thyroid cysts  resolve  with  
aspiration  in  approximately  75%  of  cases, although  some  require  second  or  
third  aspiration Surgery is indicated in cyst > 4 cm, failed aspiration in 3 attempts, 
solid components in cyst 
5) Benign neoplasms:  
 FNAC is difficult to differentiate between adenocarcinoma and adenoma 
preoperatively. If post op HPE after hemithyroidectomy is indicative of carcinoma 
completion thyroidectomy is done  
6) Treatment of thyroid carcinoma: 
i) Treatment of papillary and follicular carcinoma: 
A) Surgery  (Total thyroidectomy/Near  total thyroidectomy): 
The procedure involves removal  of  the  entire  thyroid  gland  with  
identification and  preservation  of  recurrent  laryngeal  nerves  and  
parathyroid glands.  
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PROCEDURE OF THYROIDECTOMY 
INDICATIONS 
Subtotal thyroidectomy is indicated in 
1) High risk patients with SNT 
2) Presence  pressure symptoms  
3) For cosmesis in large nodule  
4)  Toxic goiters  
5) Rarely for Riedel's struma and Hashimoto's disease. 
Patient is optimized pre-operatively to euthyroid status.  
ANAESTHESIA 
General Anaesthesia administered through endotracheal intubation is  
preferred.  
POSITION OF PATIENT 
The patient is placed in a neck extended position by placing sandbag/ 
folded sheet /inflatable thyroid pillow under the shoulders .The occiput is lowered 
on to a head ring. The hands are tucked to the to sides of patient. Reverse 
trendlenberg position is also used (Head tilt of 15 degrees). Mesh cap is used to 
cover patient hair. 
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The transverse incision is marked with silk thread about two fingers 
above the sternal notch extending upto borders of the sternocleidomastoid 
muscles. Incision is higher up for large goiters. Draping with sterile towel is 
done. 
INCISION AND EXPOSURE 
The surgeon stands to the right of  patient. A dry field is maintained if 
the various fascial planes are carefully considered during the procedure. 
The skin incision is made two finger breadth from suprasternal notch. Skin, 
subcutaneous tissue  divided. Subplatysmal plane is reached after deepening the 
incision. Flaps are raised both superiorly and inferiorly in that plane with care 
taken to avoid undue injury to the Anterior Jugular vein .Superior flap is raised 
upto the thyroid notch and inferiorly upto suprasternal notch. Skin f laps are 
held by self retaining retractors.  Investing layer of deep cervical  
fascia is divided vert ically in midline. Strap muscles are retracted 
after separating fascia adjoining them. Large goiters necessitate 
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division of strap muscles of neck for access. Dissection is done to 
achieve a cleavage between sternothyroid and thyroid gland 
facili tating a thin fascia which is held up and divided. This exposes 
the thyroid gland with i ts capsule and blood vessels.  Prethyroid 
muscles are retracted.   Right upper pole is dissected first, blunt dissection  is 
done to push thyroid capsule away to expose the superior pedicle . The superior 
pedicle is skeletonised and ligated close to the gland ensuring to avoid injury to 
superior laryngeal nerve. Middle thyroid vein should be identified and ligated to 
avoid bleeding due to undue traction of gland.  Next the lower pole is dissected on 
the right side by blunt  dissection. The inferior thyroid vessels are identified and 
ligated, avoiding injury to recurrent laryngeal nerve. Thyroidea ima veins 
sometimes encountered in lower pole are dissected and ligated. Alternatively 
lower pole may be ligated first before dissecting  upper pole. Ligation is applied 
and cut. Parathyroids are encountered at the posterior surface of gland, and are 
usually preserved. Superior is close to thyroid cartilage and inferior close to 
inferior pole. The gland is lifted and retracted and hemostats are placed across the 
gland and dissection is done to separate gland from trachea. Plane of cleavage is 
created between trachea and gland and gland is separated from trachea . Isthmus is 
then divided. Horizontally oriented clamps prevent injury to recurrent laryngeal 
nerve. Hemostasis is secured and saline wash is given to identify bleeders. 
Opposite lobe is dealt similarly. 
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CLOSURE 
Extended neck is released to verify for bleeding. Closed suction drain is 
placed in thyroid bed to prevent any fluid collection. The sternothyroid and 
sterno hyoid are then approximate. Drain is  brought out through centre  
beneath incision through stab wound. Remaining wound is closed in 
layers. Skin is closed with subcuticular sutures with non absorbable sutures. 
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POSTOPERATIVE CARE 
Laryngoscope is inserted to view vocal cord status and extubation is done. 
Oxygen is given at 4 to 5 L per minute, until the patient has reacted. Patient’s 
breathing is monitored and any respiratory distress or stridor warrants immediate 
intervention . Parenteral fluids are given till oral liquids are well torable. Injection 
Calcium Gluconate is added. 
 Early complications include  
1) Hemorrhage  
2) hoarseness and temporary aphonia 
3) vocal cord paralysis  
4) postoperative thyroid "storm." 
If hemorrhage is suspected wound is opened and hemorrhage is let out 
followed by identification of bleeders and ligation. 
Recurrent laryngeal nerve bilateral leads to vocal cord  paralysis of both 
vocal cords  tracheostomy. 
Postoperative toxicosis is managed by corticosteroids, propanolol and 
cooling blankets. Hypoparathyroidism is managed by calcium gluconate 10% 
intravenously along with  Vitamin D2 is administered normalise serum calcium 
level.  Thyroid replacement is given with levothyroxine daily. Drains are removed 
in first postoperative day. Patients are discharged after suture removal. 
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Management of Lymph nodes 
The current practice of the vast majority of endocrine surgeons with regard 
to well-differentiated thyroid cancer is to perform node dissection in the setting  of 
imageable or  palpable  nodal  disease.  If  a  neck  dissection  is  performed,  the 
preferred approach is a modified  radical  neck  dissection type III preserving  the  
internal jugular vein,  sternocleidomastoid  muscle,  and  accessory  nerve  in  the  
vast  majority of patients. 
Post op management 
i. Suppressive therapy with thyroxine 
Post-operative thyroid hormone   replacement  is  necessary  after  total  or 
near total thyroidectomy or  ablation  with  radio-iodine.  Thyroxine  is  necessary  
not only as  replacements  therapy  in  patients  total   thyroidectomy  but  has  
additional effect of  suppressing  TSH  and  reducing  growth  stimulus  for  any  
possible residual thyroid  cells.  TSH  suppression( < 0.1 microU/Ml)  reduces  
tumor  recurrence  rates  particularly in young  patients  with  thyroid cancer. 
ii. Use of RAI post-operatively 
 All patients who have undergone a total  or  near-total  thyroidectomy  for  
a papillary or follicular carcinoma larger  than  1.0  to  1.5  cm  should  be  
considered candidates for radio-iodine ablation 
131
I for ablation are given in two 
doses. Selectively young patients are given repeated 
131
I  ablation at a dose of < 30 
mCi. Higher  ablative  doses  ranging  from  100 to 150 mCi should be used  for  
older,  high-risk  patients,  particularly  those  known to have an incomplete 
resection of the primary tumor, an invasive primary tumor, or metastases. 
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Postoperative ablation is typically performed approximately 6 weeks after 
near- total or total thyroidectomy 
Complications  of RI 
Acute: 
1)  Radiation  thyroiditis   
2) Pain in bone and other distant metastasis  induced by radiation inflammation. 
3)Tumor  edema / haemorrhage. 
Late: 
1) Damage to gonads, 2) bone marrow lungs, 3) induction of other malignancies 
like bladder carcinoma, leukemia 
iii. Serum thyroglobulin measurements; 
This is done 3 months after surgery. Since even small amount of normal 
residual thyroid CA can produce significant quantity of thyroglobulin, complete 
extirpation  of  the  gland  followed  by  radioactive  iodine  ablation  is 
mandatory. If the values  go  above  10 ng/ml  it  is  suggestive  of  metastasis  or  
persistent normal thyroid tissues. 
iv. Chemotherapy 
Chemotherapy is not effective. Only indication is unresectable disease. The  
best  single  chemotherapeutic  agent for this  tumor  is  doxorubicin 
(Adriamycin).   
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v. Treatment of Anaplastic thyroid carcinoma 
At the time of diagnosis 80% will have lymph node metastases 25-50% of 
patients may have synchronous metastases survival after the diagnosis of ATC is 
very poor with the median survival in most series being less than 5 months; 
Early diagnosis with aggressive surgical therapy supplemented by external- 
beam radiation therapy and doxorubicin based chemotherapy is regarded by 
many as the most appropriate treatment.  
vi. Treatment of thyroid lymphoma 
Patients with thyroid lymphoma respond rapidly to chemotherapy [CHOP] 
– cyclophosphamide, doxorubicin, vincristine and prednisone] which is also 
associated with improved survival combined treatment with radiotherapy and 
chemotherapy is often recommended 
vii. Medullary carcinoma 
Preoperative diagnosis of medullary carcinoma warrants syndromic 
evaluation of MEN 2 a/ 2b. Pheochromocytoma should be identified with 
urinary catecholamines and isotope scans. Treatment for pheochromocytoma 
is done first. Medullary carcinoma of thyroid is treated with total 
thyroidectomy and central neck node dissection. Chemotherapy and external 
beam radiotherapy are ineffective. 
Progonosis  
Most patients with papillary carcinoma can be expected an excellent 
prognosis, with the 10-years survival rate approaching 95% for the most favorable 
stages. The clinical findings and pathologic staging, however, may alter the 
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excellent prognosis. In 1979, Cady and associates introduced AMES and Mayo 
clinic introduced AGES scoring systems. Both the AMES and the AGES clinical 
scoring systems have proved beneficial in predicting the prognosis of papillary and 
follicular cancer. 
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MATERIALS AND METHODS 
The present study on “Clinical Study of Solitary Nodule of Thyroid” has 
been conducted by utilizing cases admitted and managed in the Department of 
Surgery at Govt. Royapettah Hospital attached to Govt. Kilpauk Medical College 
Hospital, Chennai over a period of 10 months from November 2014 to Sep 2015. 
Descriptive  analysis of  50cases of solitary nodule thyroid in the specified 
period done. These cases were selected by random sampling method and studied 
in detail clinically and recorded as per the proforma. Routine investigations and 
specific investigations including FNAC of the nodule, Thyroid profile, IDL, Plain 
X-ray neck, USG neck were done in all cases. Special investigations like radio-
isotope scanning was not performed as the facilities were not available. All the 
patients were managed by surgery and diagnosis was confirmed by histo-
pathological examination. 
• Inclusion criteria: 
• Patients above the age of 12 years.  
• Patients presenting clinically with solitary nodule thyroid  
• Both male and female patients are included in study  
• Exclusion criteria: 
• Patients  below the age of 12years  
• Patients clinically with multi nodular goitre  
• Patients with lateral aberrant thyroid  
• Patients have diffuse swelling of thyroid  
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The patients were grouped according to different variables like age , sex, 
size of the nodule, site of the nodule, functional thyroid status, FNAC reports and 
histo- pathological examination reports, then analyzed and compared with the 
previous similar studies conducted elsewhere. Finally conclusions were drawn 
accordingly. 
Treatment: 
Preoperative 
Use of anti-thyroid drugs, beta-blockers, blood transfusions or any other 
medications were prescribed based on individual status and was noted 
Operative 
Position of the patient, type of anaesthesia, incision, type of operation 
planned, per- operative findings and type of operation performed were recorded. 
Post-operative 
Every patient was followed up post-operatively during the course of 
management in the hospital to note the development of and management of 
complications. 
Follow-up 
At the time of discharge, all the patients were advised to attend the 
surgical OPD regularly for follow up. Any recurrences or complications were 
noted. Thyroid functional status was assessed, accordingly thyroxine tablets 
prescribed if necessary. 
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RESULTS 
Total of 50 cases of solitary nodule of thyroid studied and following 
conclusions were drawn: 
Age Incidence: 
AGE IN YEARS NO. OF PATIENTS 
0-9 0 
10-19 2 
20-29 14 
30-39 10 
40-49 11 
50-59 9 
60-69 4 
Total 50 
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Age Incidence: 
The age of the patients ranges from 18 years to 66 years, with peaks being in 
3
rd 
to 5
th decades. The mean age of presentation is 37.26 years. Cases in 3
rd to 5
th 
decades constitutes 60% of the cases studied. 
Sex Incidence: 
Solitary nodule of thyroid are much more common in females. Out of 50 
cases studied 42 were females and 8 were males, and the ratio comes to M : F = 1 : 
5.25. Also the malignant nodules are common in females. Out of 9 cases of 
malignancy in the study, 8 were females. 
SEX NO. OF PATIENTS 
MALES 8 
FEMALES 42 
Total 50 
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CLINICAL FEATURES 
All the cases in the present study presented complaint of swelling in the 
region of the thyroid. Only few patients presented with pain, discomfort and 
dysphagia. All the mentioned additional symptoms were of mild degree. Out of 50 
cases, 3 cases had pain, 3 cases had discomfort and another 1 had dysphagia. Also 
none of the patient had lymphadenopathy which was confirmed by 
ultrasonographic examination. Two patients had symptoms of thyrotoxicosis, and 
one had features of hypothyroidism. The latter patients’ thyroid profile confirmed 
the functional status 
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Duration of symptoms: 
In our study, duration of onset symptoms varied from 15 days to 8 years. 
Also duration of malignant nodules extend from 1 month to 4 years. 
 
DURATION OF SYMPTOMS NO. OF PATIENTS 
<1MON 1 
1-3 MON 5 
3-6 MON 11 
6-12 MON 7 
1-2YRS 11 
2-5YRS 12 
>5YRS 2 
Total 50 
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SITE OF THE NODULE: 
Out of 50 cases studied, 26 cases presented with nodule in right lobe of the 
thyroid gland and  the remainder 24 in the left lobe of thyroid. One patient among 
left sided solitary nodule had undergone right lobectomy 30 years back and 
presented with recurrent nodule in the rest of the lobe. 
SITE OF THE NODULE NO. OF PATIENTS 
RIGHT 26 
LEFT 24 
Total 50 
 
 
Size of the nodule: 
In the present study, on clinical examination size of the nodule, in its 
largest dimension, varies from 2cm to 12cm. Most of the patients presented with 
the size of about 3 to 5 cm. in the study, as such there is no correlation between 
the size of the nodule and the occurrence malignant nodule. 
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 Size of the nodule No. of patients 
<1 cm 0 
1-2 cm 3 
2-3 cm 7 
3-4 cm 15 
4-5 cm 15 
5-6 cm 7 
6-7cm 1 
>7 cm 2 
Total 50 
 
 
 
 
 
 
 
 
Thyroid functional status: 
Out of 50 cases, two presented with features of thyrotoxicosis, one with 
hypothyroidism and rest all were in euthyroid state. Patients with thyrotoxicosis 
were made euthyroid using antithyroid drugs and operated and both cases turned 
out to be toxic follicular adenoma. Patient with hypothyroidism was treated with 
thyroxine. 
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USG neck revealed multiple nodules and managed by near subtotal 
thyroidectomy, and histopathological examination confirmed the diagnosis of 
multi-nodular goiter. 
 
Thyroid functional status No. of patients 
Euthyroid 47 
Hyperthyroid 2 
Hypothyroid 1 
Total 50 
 
  
 
 
 
 
 
 
 
FNAC Reports: 
Fine Needle Aspiration Cytology is the important investigation in the 
evaluation of solitary nodule of thyroid. All 50 cases were subjected to FNAC 
during the course of evaluation. Fnac reports are mainly categorized into 6 entities- 
Benign, follicular neoplasm, suspicious(of malignancy), malignant, lymphocytic 
thyroiditis, cysts. In our study, out of 12 follicular neoplasms, 4 turned out to be 
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follicular carcinoma. One suspicious (of papillary carcinoma) case confirmed 
papillary carcinoma on histopathological examination. 5 cases of papillary 
carcinoma were diagnosed pre- operatively by FNAC alone. 
Two cases diagnosed as cysts by FNAC confirmed to be simple cysts on 
histopathological examination. 
FNAC reports No. of patients 
Benign 25 
follicular neoplasm 14 
Suspicious 1 
Malignant 4 
Lymphocytic thyroiditis 3 
Cysts 3 
Total 50 
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Aetiological incidence of solitary nodule of thyroid: 
Out of 50 cases studied, common causes of solitary nodule are MNG, 
follicular adenoma and adenomatous goiter; the most common being MNG which 
constitutes about 26% of cases. 
Follicular adenoma and adenomatous goiters found almost at the same 
incidences, accounting to 24% each. 
Out of 50 cases, nine were malignant – 5 papillary carcinoma and 4 
follicular carcinoma. 
45 patients were subjected to surgery. 5 patients (2 simple cysts & 3 
Lymphocytic thyroiditis) were conservatively managed. HPE reports of 45 were 
documented 
Ultrasonography detected suspicious findings in two cases among six 
malignant cases – 1 papillary and 1 follicular. 
Three cases of papillary carcinoma were diagnosed with certainity by 
FNAC, one case was suspicious which turned out to be papillary CA on 
histopathological examination. 
Two cases of follicular carcinoma were diagnosed follicular neoplasm, one 
of them showed suspicious features on ultrasonographic examination. 
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Post Operative Histopathology in SNT 
 
HPE Reports No. of patients 
Follicular adenoma 13 
Adenomatous goitre 8 
MNG 13 
Carcinoma 9 
Lymphocytic thyroiditis 1 
Simple cyst 1 
Total 45 
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From the study, incidence of malignancy in solitary nodules is 18%. 
 
 
 
 
 
 
 
 
Solitary nodule of thyroid No. of cases 
Benign 41 
Malignant 9 
Total 50 
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Type of carcinoma: 
From the study, out of 9 carcinoma, 5 were papillary and 4 follicular: no 
case of medullary or anaplastic or lymphoma was detected. Papillary carcinoma 
accounts to 55.6% and follicular carcinoma accounts to 44.4%. 
 
 
 
 
 
 
 
TYPE OF MALIGNANCY : 
 
  
Type of carcinoma No. of cases percentage 
Papillary 5 55.6 
Follicular 4 44.4 
Medullary 0 0 
Anaplastic 0 0 
Lymphoma 0 0 
Total 9 100 
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SURGERY / OPERATIVE PROCEDURE DONE 
Depending upon the clinical diagnosis and FNAC features, all 45 out of the 
50 patients underwent surgery. Among them, patients 22 had undergone 
hemithyroidectomy,  14 cases undergone sub-total thyroidectomy and 9 cases 
undergone total thyroidectomy. 
In 3 cases, HPE after hemithyroidectomy showed follicular carcinoma, then 
completion of total thyroidectomy done 
Post-operatively, suppressive dose of thyroxine was started for patients who 
had undergone total thyroidectomy. Three cases out of 7 cases of total 
thyroidectomy showed features of hypocalcemia on 2-4 post-operative day, hence, 
they are supplemented with oral calcium and vitamin D3. 
All the cases were followed up for 6months, two cases had husky voice 
without any change in vocal cord movements. 
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CLINICAL PICTURES OF SOLITARY NODULE OF THYROID 
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DISCUSSION 
The observations and results of the present study were compared with the 
available previous similar studies. 
MEAN AGE AT PRESENTATION 
AUTHORS MEAN AGE IN YEARS 
Das DK (1999) 35 
Talepoor M(2005) 38.6 
Quari F. (2005) 36.7 
REHMAN A.U.(2009)* 34.7 
Khurshid Anwar(2012)* 37 
Present study 37.26 
 
In the study done by Quari F and Talepoor M separately in 2005, 
reported the mean age at presentation as 36.7years and 38.6years respectively. 
Khurshid Anwar reported, in 2012, the mean age of presentation as 37years. 
From the present study, the mean age at presentation found to be 37.27years, 
correlates with the previous studies. 
Most of the earlier series reported peak incidence of solitary nodule 
thyroid in the 3
rd 
and 4
th decades. Bhansali S.K 
5
(1982), in his similar study, 
reported the peak incidence in 4
th and 5
th decade. In the present study, the 
peak incidence found to be 3
rd to 5th decades, which constitutes about 60% of 
the cases studied. 
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SEX DISTRIBUTION 
AUTHORS SEX INCIDENCE(M:F) 
Dorairajan (1996) 1:9 
Das DK(1999) 1:5.39 
Gupta C(2001) 1:5 
Present study 1:5.25 
 
In the study done by Dorairajan (1996) and Das DK (1999) reported ratio 
of sex incidence as 1:9 and 1:5.39 respectively. In the present study, its found to be 
1:5.25, which correlates with Das DK STUDY (1999). 
Because of periods of fluctuations in the demands of the hormonal 
requirement in female in their life cycle (puberty, menstrual cycles, pregnancy, 
menopause), the chances of thyroid nodule formation  are very high as compared 
with male counterparts. 
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DISTRIBUTION OF NON-NEOPLASTIC AND NEOPLASTIC 
LESIONS DIAGNOSED BY FNAC 
 
AUTHORS NON- 
NEOPLASTIC 
NEOPLASTIC RATIO 
Sarda AK (1997) 487 59 8.25:1 
Das DK (1999) 346 85 4.07:1 
Gupta C (2001) 470 30 15.66 
Karur (2002) 32 15 2.13:1 
Talepoor M (2005) 325 70 4.33:1 
Hurtado Lopez M 
(2005) 
80 50 1.6:1 
Nagada (2006) 51 18 2.83:1 
Chao CT(2007) 276 264 1.04:1 
Present study 31 19 1.63:1 
 
In the present study, neoplastic conditions include adenomas and all 
malignant lesions. From the study, the ratio of non-neoplastic to neoplastic cases is 
about 1.63:1, which is comparable to the studies done earlier like Hurtado Lopez 
M(2005), Chao CT(2007) & Karur (2002) 
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DISTRIBUTION OF MALIGNANCIES BY FNAC  
AUTHORS PERCENTAGE 
Sarda Ak et al(1997) 10.8 
Karur K et al(2002) 18 
Mundsad B et al(2006) 4.16 
Present study 10 
 
In the present study, among 5 cases of papillary carcinoma, 4 were 
diagnosed with certainty by FNAC and the rest one was suspicious of malignancy. 
But 4 cases of Follicular carcinoma were initially reported as  Follicular neoplasm. 
From the study, distribution of malignancy is about 10 percentage, which is 
comparable with the earlier study  Sarda  Ak et al. 
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Aetiological incidence (in percentage): 
Series MNG Adenoma Carcinoma Others 
Total No. 
of cases 
Zaman & 
Bhagbati (1971) 83 9 8 - 2221 
Ananth Krishnan 
(1983) 12 47 2 2 104 
Bhansali (1982) 71 20 9 - 449 
Fenn (1980) 22 55 12 11 342 
Kapur (1982) 28 50 11 11 221 
Present series 13 13 9 15 50 
 
From the present study, common causes of solitary nodule is dominant 
nodule of multinodular goiter and follicular adenoma which is comparable 
with above studies. 
  
95 
 
INCIDENCE OF CARCINOMA: 
STUDY YEAR PERCENTAGE 
A S Fenn et al 1980 12.0% 
Bhansali S K 1982 9.0% 
Kapur et al 1982 11.0% 
Wagana et al 2002 16% 
Rehman A U 2009 11.47% 
Present study 2015 18% 
 
From the literature, the incidence of malignancy in thyroid nodule ranges 
from 5% to 30%. From the present study, the incidence found to be 18%, which is 
comparable with the study done by Wagana et al 2002. 
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CONCLUSIONS 
The present study is a descriptive study of 50 cases of solitary nodule of 
thyroid, admitted to Govt. Royapettah Hospital, Chennai, during the period of 
N o ve mb e r  2014 to September 2015 has been made. Though a large number 
of patients are required to come to better conclusions, based on the data and 
results obtained in the present study, the following conclusions can be drawn: 
- Solitary nodule of thyroid is more common in females. 
- Solitary nodule of thyroid is more common the age group of 20-50years. 
- Most of the patients with solitary nodule of thyroid present with swelling 
alone. 
- Most of the patients with solitary nodule of thyroid are in euthyroid state 
and only few present with toxicity and hypothyroidism. 
- Incidence of malignancy in male patients presenting with solitary nodule 
thyroid is more when compared to female patients presenting with the same. 
- commonest cause of solitary nodule of thyroid is dominant nodule of multi-
nodular goitre. 
- USG can be used to detect multi-nodular goitre in patients presenting with 
solitary nodule thyroid. 
-  FNAC is the investigation of choice in the evaluation of solitary nodule of 
thyroid. It has few pitfalls.  
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In such situations, only histopathology can confirm the exact pathology. 
It detects papillary carcinoma in a solitary nodule with high sensitivity and 
specificity. 
- Papillary carcinoma is the most common malignancy of thyroid, followed by 
follicular carcinoma. 
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SUMMARY 
A descriptive analysis of 50 cases of solitary nodule of thyroid, admitted to 
Govt. Royapettah Hospital, Chennai, during the period of November 2014 to 
September 2015 has been made and summarized below: 
- Commonest presentation of solitary nodule is swelling in front of neck. 
- The peak age at presentation of solitary nodule thyroid is 3
rd to 5
th decade, 
constituting about 60% of the cases. 
- Solitary nodule is more common in females with the ratio M:F = 1:5.25. 
- Most of the solitary nodule of thyroid are benign (89%). 
- Most of patients with solitary nodule of thyroid are in euthyroid state 
(95%). 
- After evaluation of solitary nodule thyroid, 26% of all the clinically solitary 
nodule turned out to be multi-nodular goitre. 
- Common causes of solitary nodule thyroid are MNG (26%), follicular 
adenoma (24%) and adenomatous goiter (24%). 
- Incidence of malignancy of solitary nodule is about 18%. Male to female 
ratio in case of malignant nodule is 1:5. 
- Incidence of carcinoma in males presenting as thyroid nodule is higher 
(16.67%) compared to that of females (10.20%). 
-  
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- The most common malignancy in solitary nodule thyroid is papillary 
carcinoma (55%), followed by follicular carcinoma(45%) 
- FNAC is an important investigation in the evaluation of the solitary nodule 
of thyroid. 
- Surgery has been the treatment of choice in most of the cases, either 
because of cosmetic reasons or toxicity or FNAC diagnosis of follicular 
neoplasm or malignancy. 
Transient hypocalcemia is common after total thyroidectomy for 
malignancies. 
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ANNEXURE-1 
 
PROFORMA  FOR  CLINICAL STUDY  OF  SOLITARY  NODULE OF 
 
THYROID 
 
Case No: 
Name: Hospital: 
Age:   Unit: 
Sex: D.O.A: 
Occupation: D.O.D: 
Address: 
Contact No: 
A. Clinical diagnosis: 
 
B. Chief complaint and its duration: 
a. Swelling 
b. Pain 
c. Others 
C. History of presenting illness: 
a. Swelling 
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i. Duration 
ii. Site 
iii. Mode of onset  
iv. Progress of the swelling 
v. Presence of other swelling(s) 
vi. Secondary changes 
b. Pain 
i. Duration 
ii. Onset 
iii. site 
iv. Nature 
v. Radiation 
vi. Aggravating factors 
vii. Relieving factors 
c. Pressure symptoms 
i. Dysphagia 
ii. Dyspnea 
iii. Hoarseness of voice 
iv. Voice fatigue 
d. Symptoms suggestive of BMR changes 
i. Appetite: increased/decreased/good 
ii. Weight: increased/decreased/no significant change 
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iii. Sweating: increased/decreased/no significant change 
iv. Any preference to hot or cold environment 
e. Toxic symptoms 
i. Primary toxicity 
1. Irritability 
2. Insomnia 
3. Anxiety 
4. Fear 
5. Tremors of hands 
6. Prominence of eyes 
7. Diarrhea 
8. Swelling of lower limbs- pretibial myxoedema 
ii. Secondary toxicity 
1. Palpitation 
2. Precordial pain 
3. Dyspnea on exertion 
4. Swelling of lower limbs 
f. Hypothyroid symptoms 
i. Dullness 
ii. Lethargy 
iii. Loss of hairs 
iv. Behavior-hypoactivity 
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v. Response to surroundings 
g. Menstrual history-
menorrhagia/oligimenorrhoea/amenorrhoea 
i. Flow 
ii. Days 
iii. Frequency 
h. Symptoms suggestive of malignancy 
i. Rapid increase in size 
ii. Presence of other swelling(s) in neck – lymph nodes 
iii. Recent onset of pressure symptoms/change in voice 
iv. Chest symptoms- cough/breathlessness/hemoptysis 
v. Loss of weight and loss of appetite 
D. Past history: 
i. h/o any drug intake 
ii. h/o irradiation to neck in childhood 
iii. h/o diabetes/hypertension/tuberculosis/asthma/allergy 
E. Family history 
i. h/o similar complaints in family members 
ii. h/o similar complaints in locality 
F. Personal history 
i. Diet: 
ii. Appetite: 
111 
 
iii. Sleep 
iv. Bowel and bladder habits: 
v. Habits: 
GENERAL PHYSICAL EXAMINATION 
Appearance: Pallor: 
Look:  Anxious/dull/normal Icterus: 
Built: thin/moderate/obese Cyanosis: 
Skin: Clubbing: 
Hands: warm/moist/cold 
Lymphadenopathy:                                 Nutrition: 
Tremors: 
Vitals:  
LOCAL EXAMINATION 
 
1. Inspection 
 
Swelling(s)  - number: 
-shape: 
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-size: 
-borders: 
-extent: 
-surface: 
-skin over the swelling: 
-secondary changes: 
fungation/ulceration/inflammation 
-pulsation: 
-engorged veins: 
-trachea: 
-any other swelling(s)-lymph nodes 
 
2. Palpation: 
 
-Local rise of temperature: 
-Tenderness: 
-Number: 
-Shape: 
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-Size: 
-Site: 
-Extent: 
-Borders 
-Surface: 
-Consistency: 
-Mobility -skin  
-on contraction of muscle 
                                 -anatomical plane 
-Position of trachea: 
-Carotids: normal/Displaced/Absent 
-Bruit: 
-Dilated veins: 
-Regional lymph nodes: 
3. Percussion: 
 
-over sternum: Dull/Resonant 
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4. Auscultation: 
-Tracheal position 
-Bruit 
5. Measurement of neck at the most prominent part: 
SYSTEMIC EXAMINATION 
Signs of toxicity -Primary 
-Secondary 
1. Cardiovascular system: 
2. Respiratory system: 
3. Central nervous system: 
4. Per-abdominal examination: 
CLINICAL DIAGNOSIS: 
INVESTIGATIONS: 
ROUTINE: 
HB%: Total Count: 
Differential Count: ESR: 
Bleeding Time: Clotting Time: 
Urine Routine: Albumin- ECG: 
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Sugar & microscopy- 
Random Blood Sugar: Blood Urea: 
Serum Creatinine: Chest-X-Ray: 
HIV -1&2: HBsAg: 
SPECIFIC 
INVESTIGATIONS: 
-FNAC of nodule: 
-Thyroid Profile: 
-Indirect Laryngoscopy: 
-Plain X-Ray Neck: 
-USG Neck:  
TREATMENT: 
Pre-operative: 
Surgical:-
Operative 
Findings: 
Post-
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operative: 
HISTO-PATHOLOGICAL EXAMINATION: -Macroscopic: 
 
-Microscopic: 
FOLLOW-UP: 
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KEY TO MASTER CHART 
 
AG Adenomatous goiter 
B Benign 
CA Carcinoma 
CG Colloid goiter 
FA Follicular adenoma 
FC Follicular carcinoma 
FN Follicular neoplasm 
HT Hemithyroidectomy 
L Left 
MNG Multi-nodular goiter 
NCG Nodular colloid goitre 
NTT Near total thyroidectomy 
PC Papillary carcinoma 
R Right 
SC Simple cyst of thyroid 
SNT Solitary nodule thyroid 
STT Sub total thyroidectomy 
TT Total thyroidectomy 
NA Not Applicable 
 
 
 
 
 
 
 
